Benita S. Katzenellenbogen - Publications

Affiliations: 
University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Area:
Cell Biology, Molecular Biology, Biochemistry

373 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Irani S, Tan W, Li Q, Toy W, Jones C, Gadiya M, Marra A, Katzenellenbogen JA, Carlson KE, Katzenellenbogen BS, Karimi M, Segu Rajappachetty R, Del Priore IS, Reis-Filho JS, Shen Y, et al. Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferation. The Journal of Clinical Investigation. PMID 37883178 DOI: 10.1172/JCI163242  0.457
2023 Katzenellenbogen BS, Guillen VS, Katzenellenbogen JA. Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer. Breast Cancer Research : Bcr. 25: 76. PMID 37370117 DOI: 10.1186/s13058-023-01675-8  0.316
2023 Nandi I, Smith HW, Sanguin-Gendreau V, Ji L, Pacis A, Papavasiliou V, Zuo D, Nam S, Attalla SS, Kim SH, Lusson S, Kuasne H, Fortier AM, Savage P, Martinez Ramirez C, ... ... Katzenellenbogen BS, et al. Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression. The Journal of Clinical Investigation. PMID 36795481 DOI: 10.1172/JCI162324  0.313
2022 Dey P, Wang A, Ziegler Y, Kumar S, Yan S, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS. Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast Cancer. Endocrinology. PMID 36251879 DOI: 10.1210/endocr/bqac172  0.435
2022 Zuo Q, Mogol AN, Liu YJ, Santaliz Casiano A, Chien C, Drnevich J, Imir OB, Kulkoyluoglu-Cotul E, Park NH, Shapiro DJ, Park BH, Ziegler Y, Katzenellenbogen BS, Aranda E, O'Neill JD, et al. Targeting metabolic adaptations in the breast cancer-liver metastatic niche using dietary approaches to improve endocrine therapy efficacy. Molecular Cancer Research : McR. PMID 35259269 DOI: 10.1158/1541-7786.MCR-21-0781  0.769
2021 Ziegler Y, Guillen VS, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS. Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer. Cancers. 13. PMID 34944900 DOI: 10.3390/cancers13246282  0.336
2021 Katzenellenbogen BS. Estrogen receptor gets a grip on RNA. Cell. 184: 5086-5088. PMID 34559987 DOI: 10.1016/j.cell.2021.09.012  0.415
2021 Min J, Nwachukwu JC, Min CK, Njeri JW, Srinivasan S, Rangarajan ES, Nettles CC, Sanabria Guillen V, Ziegler Y, Yan S, Carlson KE, Hou Y, Kim SH, Novick S, Pascal BD, ... ... Katzenellenbogen BS, et al. Dual-mechanism estrogen receptor inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34452998 DOI: 10.1073/pnas.2101657118  0.469
2021 Mayne CG, Toy W, Carlson KE, Bhatt T, Fanning SW, Greene GL, Katzenellenbogen BS, Chandarlapaty S, Katzenellenbogen JA, Tajkhorshid E. Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer. Molecular Cancer Research : McR. PMID 34021071 DOI: 10.1158/1541-7786.MCR-20-1017  0.428
2020 Yan S, Dey P, Ziegler Y, Jiao X, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer. Breast Cancer Research and Treatment. PMID 33001337 DOI: 10.1007/s10549-020-05948-0  0.397
2020 Dey P, Wang A, Ziegler Y, Kim SH, El-Ashry D, Katzenellenbogen JA, Katzenellenbogen BS. Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer. Cancers. 12. PMID 32961773 DOI: 10.3390/Cancers12092677  0.415
2020 Cotul EK, Zuo Q, Santaliz-Casiano A, Imir OB, Mogol AN, Tunc E, Duong K, Lee JK, Ramesh R, Odukoya E, Kesavadas MP, Ziogaite M, Smith BP, Mao C, Shapiro DJ, ... ... Katzenellenbogen BS, et al. Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers. Cancers. 12. PMID 32847042 DOI: 10.3390/Cancers12092397  0.452
2020 Laws MJ, Ziegler Y, Shahoei SH, Dey P, Kim SH, Yasuda M, Park BH, Nettles KW, Katzenellenbogen JA, Nelson ER, Katzenellenbogen BS. Suppression of breast cancer metastasis and extension of survival by a new antiestrogen in a preclinical model driven by mutant estrogen receptors. Breast Cancer Research and Treatment. PMID 32277377 DOI: 10.1007/S10549-020-05629-Y  0.483
2020 Fontaine C, Buscato M, Vinel A, Giton F, Raymond-Letron I, Kim SH, Katzenellenbogen BS, Katzenellenbogen JA, Gourdy P, Milon A, Flouriot G, Ohlsson C, Lenfant F, Arnal JF. The tissue-specific effects of different 17β-estradiol doses reveal the key sensitizing role of AF1 domain in ERα activity. Molecular and Cellular Endocrinology. 110741. PMID 32004676 DOI: 10.1016/J.Mce.2020.110741  0.366
2020 Nwachukwu J, Min J, Srinivasan SK, Rangarajan E, Guillen VS, Ziegler Y, Carlson K, Hou Y, Kim SH, Izard T, Houtman R, Katzenellenbogen BS, Nettles KW, Katzenellenbogen JA. OR12-07 Full Antagonism of Breast Cancer Cell Proliferation Can Result from Many Ligand-Induced Conformational Distortions of the Estrogen Receptor Ligand Binding Domain Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.249  0.541
2020 Katzenellenbogen JA, Min J, Srinivasan S, Rangarajan ES, Nwachukwu JC, Guillen VS, Ziegler Y, Yan S, Carlson KE, Hou Y, Kim SH, Izard T, Houtman R, Nettles KW, Katzenellenbogen BS. Abstract P6-04-10: Combining direct and indirect modes of antiestrogen ligand antagonism of estrogen receptor activity in breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P6-04-10  0.513
2020 Katzenellenbogen BS, Ziegler Y, Laws MJ, Guillen VS, Kim S, Dey P, Smith BP, Gong P, Bindman N, Zhao Y, Carlson K, Yasuda MA, Singh D, Li Z, El-Ashry D, et al. Abstract P5-05-05: Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P5-05-05  0.363
2019 Ziegler Y, Laws MJ, Sanabria Guillen V, Kim SH, Dey P, Smith BP, Gong P, Bindman N, Zhao Y, Carlson K, Yasuda MA, Singh D, Li Z, El-Ashry D, Madak-Erdogan Z, ... ... Katzenellenbogen BS, et al. Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds. Npj Breast Cancer. 5: 45. PMID 31815181 DOI: 10.1038/s41523-019-0141-7  0.353
2019 Katzenellenbogen J, Min J, Kim S, Laws M, Zhao Y, Ziegler Y, Nelson E, Shahoei S, Chu D, Park B, Katzenellenbogen B. Abstract P5-04-06: Withdrawn Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P5-04-06  0.352
2018 Sharma A, Toy W, Guillen VS, Sharma N, Min J, Carlson KE, Mayne CG, Lin S, Sabio M, Greene G, Katzenellenbogen BS, Chandarlapaty S, Katzenellenbogen JA. Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain. Acs Chemical Biology. PMID 30404440 DOI: 10.1021/Acschembio.8B00877  0.556
2018 Selvaraj UM, Zuurbier K, Whoolery C, Plautz EJ, Chambliss KL, Kong X, Zhang S, Kim SH, Katzenellenbogen BS, Katzenellenbogen JA, Mineo C, Shaul PW, Stowe AM. Selective Non-nuclear Estrogen Receptor Activation Decreases Stroke Severity and Promotes Functional Recovery in Female Mice. Endocrinology. PMID 30256928 DOI: 10.1210/En.2018-00600  0.398
2018 Katzenellenbogen JA, Mayne CG, Katzenellenbogen BS, Greene GL, Chandarlapaty S. Publisher Correction: Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance. Nature Reviews. Cancer. PMID 30185950 DOI: 10.1038/S41568-018-0053-0  0.351
2018 Wang L, Guillen VS, Sharma N, Flessa K, Min J, Carlson KE, Toy W, Braqi S, Katzenellenbogen BS, Katzenellenbogen JA, Chandarlapaty S, Sharma A. New Class of Selective Estrogen Receptor Degraders (SERDs): Expanding the Toolbox of PROTAC Degrons. Acs Medicinal Chemistry Letters. 9: 803-808. PMID 30128071 DOI: 10.1021/Acsmedchemlett.8B00106  0.551
2018 Guivarc'h E, Buscato M, Guihot AL, Favre J, Vessières E, Grimaud L, Wakim J, Melhem NJ, Zahreddine R, Adlanmerini M, Loufrani L, Knauf C, Katzenellenbogen JA, Katzenellenbogen BS, Foidart JM, et al. Predominant Role of Nuclear Versus Membrane Estrogen Receptor α in Arterial Protection: Implications for Estrogen Receptor α Modulation in Cardiovascular Prevention/Safety. Journal of the American Heart Association. 7. PMID 29959137 DOI: 10.1161/Jaha.118.008950  0.45
2018 Katzenellenbogen JA, Mayne CG, Katzenellenbogen BS, Greene GL, Chandarlapaty S. Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance. Nature Reviews. Cancer. PMID 29662238 DOI: 10.1038/S41568-018-0001-Z  0.538
2018 Vinel A, Coudert AE, Buscato M, Valera MC, Agnès O, Katzenellenbogen JA, Katzenellenbogen BS, Berdal A, Babajko S, Arnal JF, Fontaine C. Respective role of membrane and nuclear estrogen receptor (ER) α in the mandible of growing mice: implications for ERα modulation. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 29624728 DOI: 10.1002/Jbmr.3434  0.371
2018 Miranda CL, Johnson LA, de Montgolfier O, Elias VD, Ullrich LS, Hay JJ, Paraiso IL, Choi J, Reed RL, Revel JS, Kioussi C, Bobe G, Iwaniec UT, Turner RT, Katzenellenbogen BS, et al. Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese Mice. Scientific Reports. 8: 613. PMID 29330372 DOI: 10.1038/S41598-017-18992-6  0.305
2018 Laws MJ, Kim SH, Min J, Zhao Y, Ziegler Y, Chu D, Park BH, Katzenellenbogen JA, Katzenellenbogen BS. Abstract 946: Suppression of breast cancer metastasis and extension of host animal survival by a new adamantyl antiestrogen, K-07, in a preclinical breast cancer metastasis model driven by constitutively active mutant estrogen receptors Cancer Research. 78: 946-946. DOI: 10.1158/1538-7445.Am2018-946  0.493
2018 Laws MJ, Kim SH, Ziegler Y, Bindman N, Gong P, Guillen VS, Yasuda M, Singh D, El-Ashry D, Katzenellenbogen JA, Katzenellenbogen BS. Abstract 1955: Suppression of hormone receptor-positive and triple-negative breast cancers by new inhibitors of the transcription factor FOXM1 Cancer Research. 78: 1955-1955. DOI: 10.1158/1538-7445.Am2018-1955  0.482
2017 Katzenellenbogen BS, Zhao Y, Laws MJ, Sanabria Guillen V, Ziegler Y, Min J, Sharma A, Kim SH, Chu D, Park BH, Oesterreich S, Mao C, Shapiro DJ, Nettles KW, Katzenellenbogen JA. Structurally novel antiestrogens elicit differential responses from constitutively active mutant estrogen receptors in breast cancer cells and tumors. Cancer Research. PMID 28904064 DOI: 10.1158/0008-5472.Can-17-1265  0.531
2017 Min J, Guillen VS, Sharma A, Zhao Y, Ziegler Y, Gong P, Mayne CG, Srinivasan S, Kim SH, Carlson KE, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA. Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor (ER)-Mediated Activities in Breast Cancer Cells. Journal of Medicinal Chemistry. PMID 28657320 DOI: 10.1021/Acs.Jmedchem.7B00585  0.52
2017 Lu W, Katzenellenbogen BS. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer. Hormones & Cancer. PMID 28577282 DOI: 10.1007/S12672-017-0298-1  0.512
2017 Arnal JF, Lenfant F, Metivier R, Flouriot G, Henrion D, Adlanmerini M, Fontaine C, Gourdy P, Chambon P, Katzenellenbogen B, Katzenellenbogen J. Membrane and Nuclear Estrogen Receptor Alpha Actions: From Tissue Specificity to Medical Implications. Physiological Reviews. 97: 1045-1087. PMID 28539435 DOI: 10.1152/Physrev.00024.2016  0.46
2017 Srinivasan S, Nwachukwu JC, Bruno NE, Dharmarajan V, Goswami D, Kastrati I, Novick S, Nowak J, Cavett V, Zhou HB, Boonmuen N, Zhao Y, Min J, Frasor J, Katzenellenbogen BS, et al. Corrigendum: Full antagonism of the estrogen receptor without a prototypical ligand side chain. Nature Chemical Biology. 13: 691. PMID 28514424 DOI: 10.1038/Nchembio0617-691C  0.636
2017 Srinivasan S, Nwachukwu JC, Bruno NE, Dharmarajan V, Goswami D, Kastrati I, Novick S, Nowak J, Cavett V, Zhou HB, Boonmuen N, Zhao Y, Min J, Frasor J, Katzenellenbogen BS, et al. Erratum: Full antagonism of the estrogen receptor without a prototypical ligand side chain. Nature Chemical Biology. 13: 691. PMID 28514419 DOI: 10.1038/nchembio0617-691b  0.693
2017 Menazza S, Sun J, Appachi S, Chambliss KL, Kim SH, Aponte A, Khan S, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW, Murphy E. Non-nuclear estrogen receptor alpha activation in endothelium reduces cardiac ischemia-reperfusion injury in mice. Journal of Molecular and Cellular Cardiology. PMID 28457941 DOI: 10.1016/J.Yjmcc.2017.04.004  0.476
2017 Madak-Erdogan Z, Charn TH, Jiang Y, Liu ET, Katzenellenbogen JA, Katzenellenbogen BS. Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators. Molecular Systems Biology. 13: 929. PMID 28442489 DOI: 10.15252/Msb.20177595  0.388
2017 Martin A, Yu J, Xiong J, Khalid AB, Katzenellenbogen B, Kim SH, Katzenellenbogen JA, Malaivijitnond S, Gabet Y, Krum SA, Frenkel B. Estrogens and Androgens Inhibit Association of RANKL with the Pre-osteoblast Membrane through Post-translational Mechanisms. Journal of Cellular Physiology. PMID 28213978 DOI: 10.1002/Jcp.25862  0.354
2017 Christenson JL, Butterfield KT, Spoelstra NS, Norris JD, Josan JS, Pollock JA, McDonnell DP, Katzenellenbogen BS, Katzenellenbogen JA, Richer JK. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression. Hormones & Cancer. PMID 28194662 DOI: 10.1007/S12672-017-0285-6  0.462
2017 Nelson AW, Groen AJ, Miller JL, Warren AY, Holmes KA, Tarulli GA, Tilley WD, Katzenellenbogen BS, Hawse JR, Gnanapragasam VJ, Carroll JS. Corrigendum to "Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity" [Mol. Cell Endocrinol. 440 (2016) 138-150]. Molecular and Cellular Endocrinology. 443: 175. PMID 28183459 DOI: 10.1016/J.Mce.2017.01.048  0.409
2017 Sun J, Menazza S, Appachi S, Chambliss K, Kim S, Aponte A, Khan S, Katzenellenbogen J, Katzenellenbogen B, Shaul P, Murphy E. Membrane delimited estrogen receptor activation protects heart against ischemic-reperfusion injury in mice with cardiac but not endothelial specific ablation of ERα Journal of Molecular and Cellular Cardiology. 112: 139-140. DOI: 10.1016/J.Yjmcc.2017.07.030  0.334
2016 Nelson AW, Groen AJ, Miller JL, Warren AY, Holmes KA, Tarulli GA, Tilley WD, Katzenellenbogen BS, Hawse JR, Gnanapragasam VJ, Carroll JS. Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity. Molecular and Cellular Endocrinology. PMID 27889472 DOI: 10.1016/J.Mce.2016.11.016  0.419
2016 Srinivasan S, Nwachukwu JC, Bruno NE, Dharmarajan V, Goswami D, Kastrati I, Novick S, Nowak J, Cavett V, Zhou HB, Boonmuen N, Zhao Y, Min J, Frasor J, Katzenellenbogen BS, et al. Full antagonism of the estrogen receptor without a prototypical ligand side chain. Nature Chemical Biology. PMID 27870835 DOI: 10.1038/Nchembio.2236  0.728
2016 Tryfonidis K, Zardavas D, Katzenellenbogen BS, Piccart M. Endocrine treatment in breast cancer: Cure, resistance and beyond. Cancer Treatment Reviews. 50: 68-81. PMID 27643748 DOI: 10.1016/J.Ctrv.2016.08.008  0.356
2016 Chambliss KL, Barrera J, Umetani M, Umetani J, Kim SH, Madak-Erdogan Z, Huang L, Katzenellenbogen BS, Katzenellenbogen JA, Mineo C, Shaul PW. Non-Nuclear Estrogen Receptor Activation Improves Hepatic Steatosis in Female Mice. Endocrinology. en20151629. PMID 27552247 DOI: 10.1210/En.2015-1629  0.482
2016 Gong P, Madak-Erdogan Z, Flaws JA, Shapiro DJ, Katzenellenbogen JA, Katzenellenbogen BS. Estrogen receptor-α and aryl hydrocarbon receptor involvement in the actions of botanical estrogens in target cells. Molecular and Cellular Endocrinology. PMID 27543265 DOI: 10.1016/J.Mce.2016.08.025  0.605
2016 Madak-Erdogan Z, Kim SH, Gong P, Zhao YC, Zhang H, Chambliss KL, Carlson KE, Mayne CG, Shaul PW, Korach KS, Katzenellenbogen JA, Katzenellenbogen BS. Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues. Science Signaling. 9: ra53. PMID 27221711 DOI: 10.1126/Scisignal.Aad8170  0.523
2016 Katzenellenbogen BS, Katzenellenbogen JA, Madak-Erdogan Z, VanHook AM. Science Signaling podcast for 24 May 2016: Designer estrogens. Science Signaling. 9: pc12. PMID 27221709 DOI: 10.1126/Scisignal.Aag1040  0.426
2016 Bhatt S, Stender JD, Joshi S, Wu G, Katzenellenbogen BS. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells. Oncogene. PMID 27065334 DOI: 10.1038/Onc.2016.105  0.839
2016 Fanning SW, Mayne CG, Dharmarajan V, Carlson KE, Martin TA, Novick SJ, Toy W, Green B, Panchamukhi S, Katzenellenbogen BS, Tajkhorshid E, Griffin PR, Shen Y, Chandarlapaty S, Katzenellenbogen JA, et al. Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation. Elife. 5. PMID 26836308 DOI: 10.7554/Elife.12792  0.461
2015 Madak-Erdogan Z, Gong P, Katzenellenbogen BS. Differential Utilization of Nuclear and Extranuclear Receptor Signaling Pathways in the Actions of Estrogens, SERMs, and a Tissue-Selective Estrogen Complex (TSEC). The Journal of Steroid Biochemistry and Molecular Biology. PMID 26689478 DOI: 10.1016/J.Jsbmb.2015.12.008  0.581
2015 Aumsuwan P, Khan SI, Khan IA, Ali Z, Avula B, Walker LA, Shariat-Madar Z, Helferich WG, Katzenellenbogen BS, Dasmahapatra AK. The anticancer potential of steroidal saponin, dioscin, isolated from wild yam (Dioscorea villosa) root extract in invasive human breast cancer cell line MDA-MB-231 in vitro. Archives of Biochemistry and Biophysics. PMID 26682631 DOI: 10.1016/J.Abb.2015.12.001  0.411
2015 Zhao Y, Chen Y, Kuang Y, Bagchi MK, Taylor RN, Katzenellenbogen JA, Katzenellenbogen BS. Multiple Beneficial Roles of Repressor of Estrogen Receptor Activity (REA) in Suppressing the Progression of Endometriosis. Endocrinology. en20151324. PMID 26653759 DOI: 10.1210/En.2015-1324  0.394
2015 Boonmuen N, Gong P, Ali Z, Chittiboyina AG, Khan I, Doerge DR, Helferich WG, Carlson KE, Martin T, Piyachaturawat P, Katzenellenbogen JA, Katzenellenbogen BS. Licorice Root Components in Dietary Supplements are Selective Estrogen Receptor Modulators with a Spectrum of Estrogenic and Anti-Estrogenic Activities. Steroids. PMID 26631549 DOI: 10.1016/J.Steroids.2015.11.006  0.405
2015 Smirnova NF, Fontaine C, Buscato M, Lupieri A, Vinel A, Valera MC, Guillaume M, Malet N, Foidart JM, Raymond-Letron I, Lenfant F, Gourdy P, Katzenellenbogen BS, Katzenellenbogen JA, Laffargue M, et al. The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells. Circulation Research. 117: 770-8. PMID 26316608 DOI: 10.1161/Circresaha.115.306416  0.428
2015 Valéra MC, Fontaine C, Lenfant F, Cabou C, Guillaume M, Smirnova N, Kim SH, Chambon P, Katzenellenbogen JA, Katzenellenbogen BS, Payrastre B, Arnal JF. Protective Hematopoietic Effect of Estrogens in a Mouse Model of Thrombosis: Respective Roles of Nuclear Versus Membrane Estrogen Receptor α. Endocrinology. 156: 4293-301. PMID 26280130 DOI: 10.1210/En.2015-1522  0.424
2015 Kim SH, Madak-Erdogan Z, Bae SC, Carlson KE, Mayne CG, Granick S, Katzenellenbogen BS, Katzenellenbogen JA. Ligand Accessibility and Bioactivity of a Hormone-Dendrimer Conjugate Depend on pH and pH History. Journal of the American Chemical Society. PMID 26186415 DOI: 10.1021/Jacs.5B05952  0.351
2015 Zhao Y, Gong P, Chen Y, Nwachukwu JC, Srinivasan S, Ko C, Bagchi MK, Taylor RN, Korach KS, Nettles KW, Katzenellenbogen JA, Katzenellenbogen BS. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis. Science Translational Medicine. 7: 271ra9. PMID 25609169 DOI: 10.1126/Scitranslmed.3010626  0.412
2015 Paterni I, Bertini S, Granchi C, Tuccinardi T, Macchia M, Martinelli A, Caligiuri I, Toffoli G, Rizzolio F, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Minutolo F. Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model. Journal of Medicinal Chemistry. 58: 1184-94. PMID 25559213 DOI: 10.1021/Jm501829F  0.453
2015 Aumsuwan P, Khan SI, Khan IA, Avula B, Walker LA, Helferich WG, Katzenellenbogen BS, Dasmahapatra AK. Evaluation of wild yam (Dioscorea villosa) root extract as a potential epigenetic agent in breast cancer cells. In Vitro Cellular & Developmental Biology. Animal. 51: 59-71. PMID 25148825 DOI: 10.1007/S11626-014-9807-5  0.454
2014 Gong P, Madak-Erdogan Z, Li J, Cheng J, Greenlief CM, Helferich W, Katzenellenbogen JA, Katzenellenbogen BS. Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens. Nuclear Receptor Signaling. 12: e001. PMID 25363786 DOI: 10.1621/Nrs.12001  0.499
2014 Abot A, Fontaine C, Buscato M, Solinhac R, Flouriot G, Fabre A, Drougard A, Rajan S, Laine M, Milon A, Muller I, Henrion D, Adlanmerini M, Valéra MC, Gompel A, ... ... Katzenellenbogen BS, et al. The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation. Embo Molecular Medicine. 6: 1328-46. PMID 25214462 DOI: 10.15252/Emmm.201404112  0.485
2014 Bergamaschi A, Madak-Erdogan Z, Kim YJ, Choi YL, Lu H, Katzenellenbogen BS. The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells. Breast Cancer Research : Bcr. 16: 436. PMID 25213081 DOI: 10.1186/S13058-014-0436-4  0.5
2014 Holton SE, Bergamaschi A, Katzenellenbogen BS, Bhargava R. Integration of molecular profiling and chemical imaging to elucidate fibroblast-microenvironment impact on cancer cell phenotype and endocrine resistance in breast cancer. Plos One. 9: e96878. PMID 24816718 DOI: 10.1371/Journal.Pone.0096878  0.437
2014 Mir M, Bergamaschi A, Katzenellenbogen BS, Popescu G. Highly sensitive quantitative imaging for monitoring single cancer cell growth kinetics and drug response. Plos One. 9: e89000. PMID 24558461 DOI: 10.1371/Journal.Pone.0089000  0.349
2014 Madak-Erdogan Z, Ventrella R, Petry L, Katzenellenbogen BS. Novel roles for ERK5 and cofilin as critical mediators linking ERα-driven transcription, actin reorganization, and invasiveness in breast cancer. Molecular Cancer Research : McR. 12: 714-27. PMID 24505128 DOI: 10.1158/1541-7786.Mcr-13-0588  0.486
2014 Clark S, Rainville J, Zhao X, Katzenellenbogen BS, Pfaff D, Vasudevan N. Estrogen receptor-mediated transcription involves the activation of multiple kinase pathways in neuroblastoma cells Journal of Steroid Biochemistry and Molecular Biology. 139: 45-53. PMID 24121066 DOI: 10.1016/J.Jsbmb.2013.09.010  0.516
2014 Madak-Erdogan Z, El-Ashry D, Katzenellenbogen BS. Abstract 4169: ERK2 functional chromatin footprints in patient-derived breast tumor cells predict molecular subtype, clinical outcome, and drug response in breast cancers Cancer Research. 74: 4169-4169. DOI: 10.1158/1538-7445.Am2014-4169  0.417
2014 Fontaine C, Abot A, Solinhac R, Drougard A, Fabre A, Buscato M, Milon A, Rajan S, Laine M, Henrion D, Mestdagt M, Raymond-Letron I, Flouriot G, Knauf C, Katzenellenbogen BS, et al. 0218: The uterine and vascular actions of estetrol delineate an original distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation Archives of Cardiovascular Diseases Supplements. 6: 8. DOI: 10.1016/S1878-6480(14)71283-2  0.444
2013 Jiang Y, Gong P, Madak-Erdogan Z, Martin T, Jeyakumar M, Carlson K, Khan I, Smillie TJ, Chittiboyina AG, Rotte SC, Helferich WG, Katzenellenbogen JA, Katzenellenbogen BS. Mechanisms enforcing the estrogen receptor β selectivity of botanical estrogens. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 4406-18. PMID 23882126 DOI: 10.1096/Fj.13-234617  0.613
2013 Madak-Erdogan Z, Charn TH, Jiang Y, Liu ET, Katzenellenbogen JA, Katzenellenbogen BS. Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators. Molecular Systems Biology. 9: 676. PMID 23774759 DOI: 10.1038/Msb.2013.28  0.587
2013 Bartell SM, Han L, Kim HN, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS, Chambliss KL, Shaul PW, Roberson PK, Weinstein RS, Jilka RL, Almeida M, Manolagas SC. Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass. Molecular Endocrinology (Baltimore, Md.). 27: 649-56. PMID 23443267 DOI: 10.1210/Me.2012-1368  0.389
2013 Zhao Y, Park S, Bagchi MK, Taylor RN, Katzenellenbogen BS. The coregulator, repressor of estrogen receptor activity (REA), is a crucial regulator of the timing and magnitude of uterine decidualization. Endocrinology. 154: 1349-60. PMID 23392257 DOI: 10.1210/En.2012-2026  0.475
2013 Bergamaschi A, Frasor J, Borgen K, Stanculescu A, Johnson P, Rowland K, Wiley EL, Katzenellenbogen BS. 14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers. Breast Cancer Research and Treatment. 137: 689-96. PMID 23271328 DOI: 10.1007/S10549-012-2390-0  0.684
2013 Kim K, Madak-Erdogan Z, Ventrella R, Katzenellenbogen BS. A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties. Hormones & Cancer. 4: 78-91. PMID 23250869 DOI: 10.1007/S12672-012-0129-3  0.648
2013 Bergamaschi A, Madak-Erdogan Z, Lu H, Katzenellenbogen BS. Abstract C85: FOXM1-dependent gene expression program controls cancer stem cell and metastasis properties of breast cancer cells Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C85  0.471
2013 Holton SE, Bergamaschi A, Katzenellenbogen BS, Bhargava R. Abstract 503: Mammary fibroblasts induce hormone-independent growth in estrogen receptor-positive breast cancer cells via an epithelial-to-mesenchymal transition in a 3D cell culture model. Cancer Research. 73: 503-503. DOI: 10.1158/1538-7445.Am2013-503  0.488
2013 Erdogan ZM, Bergamaschi A, Ventrella R, Lu H, Katzenellenbogen BS. Abstract 1316: Estrogen receptor-α dictates the subcellular localization of ERK5 to control differential proliferation and invasion programs of breast cancer cells. Cancer Research. 73: 1316-1316. DOI: 10.1158/1538-7445.Am2013-1316  0.473
2013 Bergamaschi A, Madak-Erdogan Z, Lu H, Katzenellenbogen BS. Abstract 1074: Genome-wide analysis of FOXM1 binding and involvement of FOXM1 in cancer stem cell and metastasis properties of endocrine-sensitive and resistant breast cancer cells. Endocrinology. 73: 1074-1074. DOI: 10.1158/1538-7445.Am2013-1074  0.379
2012 Park S, Yoon S, Zhao Y, Park SE, Liao L, Xu J, Lydon JP, DeMayo FJ, O'Malley BW, Bagchi MK, Katzenellenbogen BS. Uterine development and fertility are dependent on gene dosage of the nuclear receptor coregulator REA. Endocrinology. 153: 3982-94. PMID 22585830 DOI: 10.1210/En.2012-1044  0.649
2012 Bhatt S, Xiao Z, Meng Z, Katzenellenbogen BS. Phosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCF(Skp2) proteasomal complex. Molecular and Cellular Biology. 32: 1928-43. PMID 22431515 DOI: 10.1128/Mcb.06561-11  0.72
2012 Madak-Erdogan Z, Katzenellenbogen BS. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140. Toxicological Sciences : An Official Journal of the Society of Toxicology. 125: 401-11. PMID 22071320 DOI: 10.1093/Toxsci/Kfr300  0.525
2012 Stossi F, Madak-Erdoǧan Z, Katzenellenbogen BS. Macrophage-elicited loss of estrogen receptor-α in breast cancer cells via involvement of MAPK and c-Jun at the ESR1 genomic locus Oncogene. 31: 1825-1834. PMID 21860415 DOI: 10.1038/Onc.2011.370  0.472
2012 Bergamaschi A, Katzenellenbogen BS. Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance Oncogene. 31: 39-47. PMID 21666713 DOI: 10.1038/Onc.2011.223  0.335
2012 Bergamaschi A, Frasor JM, Borgen K, Stanculescu A, Johnson P, Rowland K, Wiley EL, Katzenellenbogen BS. Abstract 434: Identification of 14-3-3α as a predictor of early time to recurrence and a molecular target in metastatic hormone receptor-positive and -negative breast cancers Cancer Research. 72: 434-434. DOI: 10.1158/1538-7445.Am2012-434  0.707
2012 Holton SE, Bergamaschi A, Katzenellenbogen BS, Bhargava R. Abstract 4053: A label-free spectroscopic signature associated with hormone sensitivity in 3D co-culture models of breast cancer Cancer Research. 72: 4053-4053. DOI: 10.1158/1538-7445.Am2012-4053  0.42
2011 Stender JD, Stossi F, Funk CC, Charn TH, Barnett DH, Katzenellenbogen BS. The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 25: 1699-709. PMID 21868451 DOI: 10.1210/Me.2011-0102  0.837
2011 Park S, Zhao Y, Yoon S, Xu J, Liao L, Lydon J, DeMayo F, O'Malley BW, Katzenellenbogen BS. Repressor of estrogen receptor activity (REA) is essential for mammary gland morphogenesis and functional activities: studies in conditional knockout mice. Endocrinology. 152: 4336-49. PMID 21862609 DOI: 10.1210/En.2011-1100  0.457
2011 Bergamaschi A, Christensen BL, Katzenellenbogen BS. Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis. Breast Cancer Research : Bcr. 13: R70. PMID 21707964 DOI: 10.1186/Bcr2913  0.474
2011 He B, Kim TH, Kommagani R, Feng Q, Lanz RB, Jeong JW, DeMayo FJ, Katzenellenbogen BS, Lydon JP, O'Malley BW. Estrogen-regulated prohibitin is required for mouse uterine development and adult function. Endocrinology. 152: 1047-56. PMID 21209023 DOI: 10.1210/En.2010-0732  0.541
2011 Madak-Erdogan Z, Lupien M, Stossi F, Brown M, Katzenellenbogen BS. Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs. Molecular and Cellular Biology. 31: 226-36. PMID 20956553 DOI: 10.1128/Mcb.00821-10  0.516
2011 Minutolo F, Macchia M, Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor β ligands: recent advances and biomedical applications. Medicinal Research Reviews. 31: 364-442. PMID 19967775 DOI: 10.1002/Med.20186  0.534
2011 Bergamaschi A, Katzenellenbogen B. Abstract 939: Mechanistic basis of tamoxifen-associated development of endocrine resistance in breast cancer Cancer Research. 71: 939-939. DOI: 10.1158/1538-7445.Am2011-939  0.472
2010 Santollo J, Katzenellenbogen BS, Katzenellenbogen JA, Eckel LA. Activation of ERα is necessary for estradiol's anorexigenic effect in female rats. Hormones and Behavior. 58: 872-7. PMID 20807534 DOI: 10.1016/J.Yhbeh.2010.08.012  0.444
2010 Marshall GM, Gherardi S, Xu N, Neiron Z, Trahair T, Scarlett CJ, Chang DK, Liu PY, Jankowski K, Iraci N, Haber M, Norris MD, Keating J, Sekyere E, Jonquieres G, ... ... Katzenellenbogen BS, et al. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. Oncogene. 29: 5957-68. PMID 20697349 DOI: 10.1038/Onc.2010.332  0.342
2010 Wong WP, Tiano JP, Liu S, Hewitt SC, Le May C, Dalle S, Katzenellenbogen JA, Katzenellenbogen BS, Korach KS, Mauvais-Jarvis F. Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proceedings of the National Academy of Sciences of the United States of America. 107: 13057-62. PMID 20616010 DOI: 10.1073/Pnas.0914501107  0.384
2010 Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, Madak-Erdogan Z, Maggi A, Dineen SP, Roland CL, Hui DY, ... ... Katzenellenbogen BS, et al. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. The Journal of Clinical Investigation. 120: 2319-30. PMID 20577047 DOI: 10.1172/Jci38291  0.562
2010 Stender JD, Kim K, Charn TH, Komm B, Chang KC, Kraus WL, Benner C, Glass CK, Katzenellenbogen BS. Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Molecular and Cellular Biology. 30: 3943-55. PMID 20547749 DOI: 10.1128/Mcb.00118-10  0.842
2010 Kieser KJ, Kim DW, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA. Characterization of the pharmacophore properties of novel selective estrogen receptor downregulators (SERDs). Journal of Medicinal Chemistry. 53: 3320-9. PMID 20334372 DOI: 10.1021/Jm100047K  0.515
2010 Charn TH, Liu ET, Chang EC, Lee YK, Katzenellenbogen JA, Katzenellenbogen BS. Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection. Molecular Endocrinology (Baltimore, Md.). 24: 47-59. PMID 19897598 DOI: 10.1210/Me.2009-0252  0.715
2010 Marshall GM, Gherardi S, Xu N, Neiron Z, Trahair T, Scarlett C, Chang DK, Liu PY, Jankowski K, Iraci N, Haber M, Norris MD, Stossi F, Katzenellenbogen BS, Biankin AV, et al. Abstract 4869: Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects Cancer Research. 70: 4869-4869. DOI: 10.1158/1538-7445.Am10-4869  0.364
2009 Waibel M, Kieser KJ, Carlson KE, Stossi F, Katzenellenbogen BS, Katzenellenbogen JA. Phenethyl pyridines with non-polar internal substituents as selective ligands for estrogen receptor beta. European Journal of Medicinal Chemistry. 44: 3560-70. PMID 19394116 DOI: 10.1016/J.Ejmech.2009.03.013  0.45
2009 Waibel M, De Angelis M, Stossi F, Kieser KJ, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA. Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor beta. European Journal of Medicinal Chemistry. 44: 3412-24. PMID 19286283 DOI: 10.1016/J.Ejmech.2009.02.006  0.464
2009 Stossi F, Madak-Erdogan Z, Katzenellenbogen BS. Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1. Molecular and Cellular Biology. 29: 1749-59. PMID 19188451 DOI: 10.1128/Mcb.01476-08  0.499
2009 Achari Y, Lu T, Katzenellenbogen BS, Hart DA. Distinct roles for AF-1 and -2 of ER-alpha in regulation of MMP-13 promoter activity. Biochimica Et Biophysica Acta. 1792: 211-20. PMID 19185056 DOI: 10.1016/J.Bbadis.2009.01.002  0.371
2009 Zhou HB, Carlson KE, Stossi F, Katzenellenbogen BS, Katzenellenbogen JA. Analogs of methyl-piperidinopyrazole (MPP): antiestrogens with estrogen receptor alpha selective activity. Bioorganic & Medicinal Chemistry Letters. 19: 108-10. PMID 19014882 DOI: 10.1016/J.Bmcl.2008.11.006  0.425
2009 Sengupta S, Schiff R, Katzenellenbogen BS. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells. Breast Cancer Research and Treatment. 117: 243-51. PMID 18807177 DOI: 10.1007/S10549-008-0186-Z  0.568
2008 Sheng S, Barnett DH, Katzenellenbogen BS. Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells. Molecular and Cellular Endocrinology. 296: 1-9. PMID 18951949 DOI: 10.1016/J.Mce.2008.09.022  0.729
2008 Madak-Erdogan Z, Kieser KJ, Kim SH, Komm B, Katzenellenbogen JA, Katzenellenbogen BS. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Molecular Endocrinology (Baltimore, Md.). 22: 2116-27. PMID 18617595 DOI: 10.1210/Me.2008-0059  0.514
2008 Alyea RA, Laurence SE, Kim SH, Katzenellenbogen BS, Katzenellenbogen JA, Watson CS. The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. Journal of Neurochemistry. 106: 1525-33. PMID 18489713 DOI: 10.1111/J.1471-4159.2008.05491.X  0.423
2008 Barnett DH, Sheng S, Charn TH, Waheed A, Sly WS, Lin CY, Liu ET, Katzenellenbogen BS. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Research. 68: 3505-15. PMID 18451179 DOI: 10.1158/0008-5472.Can-07-6151  0.699
2008 Paulmurugan R, Tamrazi A, Katzenellenbogen JA, Katzenellenbogen BS, Gambhir SS. A human estrogen receptor (ER)alpha mutation with differential responsiveness to nonsteroidal ligands: novel approaches for studying mechanism of ER action. Molecular Endocrinology (Baltimore, Md.). 22: 1552-64. PMID 18451095 DOI: 10.1210/Me.2007-0570  0.581
2008 Nettles KW, Bruning JB, Gil G, Nowak J, Sharma SK, Hahm JB, Kulp K, Hochberg RB, Zhou H, Katzenellenbogen JA, Katzenellenbogen BS, Kim Y, Joachmiak A, Greene GL. NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nature Chemical Biology. 4: 241-7. PMID 18344977 DOI: 10.1038/Nchembio.76  0.466
2008 Minutolo F, Bellini R, Bertini S, Carboni I, Lapucci A, Pistolesi L, Prota G, Rapposelli S, Solati F, Tuccinardi T, Martinelli A, Stossi F, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, et al. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta. Journal of Medicinal Chemistry. 51: 1344-51. PMID 18269232 DOI: 10.1021/Jm701396G  0.436
2008 Chang EC, Charn TH, Park SH, Helferich WG, Komm B, Katzenellenbogen JA, Katzenellenbogen BS. Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Molecular Endocrinology (Baltimore, Md.). 22: 1032-43. PMID 18258689 DOI: 10.1210/Me.2007-0356  0.731
2008 He B, Feng Q, Mukherjee A, Lonard DM, DeMayo FJ, Katzenellenbogen BS, Lydon JP, O'Malley BW. A repressive role for prohibitin in estrogen signaling. Molecular Endocrinology (Baltimore, Md.). 22: 344-60. PMID 17932104 DOI: 10.1210/Me.2007-0400  0.583
2008 Nettles KW, Bruning JB, Gil G, Nowak J, Sharma SK, Hahm JB, Kulp K, Hochberg RB, Zhou H, Katzenellenbogen JA, Katzenellenbogen BS, Kim Y, Joachimiak A, Greene GL. Corrigendum: NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses (Nature Chemical Biology (2008) 4, (241-247)) Nature Chemical Biology. 4: 379. DOI: 10.1038/Nchembio0608-379B  0.477
2007 Zhou HB, Nettles KW, Bruning JB, Kim Y, Joachimiak A, Sharma S, Carlson KE, Stossi F, Katzenellenbogen BS, Greene GL, Katzenellenbogen JA. Elemental Isomerism: A Boron-Nitrogen Surrogate for a Carbon-Carbon Double Bond Increases the Chemical Diversity of Estrogen Receptor Ligands Chemistry and Biology. 14: 659-669. PMID 17584613 DOI: 10.1016/J.Chembiol.2007.04.009  0.424
2007 Stender JD, Frasor J, Komm B, Chang KC, Kraus WL, Katzenellenbogen BS. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Molecular Endocrinology (Baltimore, Md.). 21: 2112-23. PMID 17550982 DOI: 10.1210/Me.2006-0474  0.851
2007 Lin CY, Vega VB, Thomsen JS, Zhang T, Kong SL, Xie M, Chiu KP, Lipovich L, Barnett DH, Stossi F, Yeo A, George J, Kuznetsov VA, Lee YK, Charn TH, ... ... Katzenellenbogen BS, et al. Whole-genome cartography of estrogen receptor alpha binding sites. Plos Genetics. 3: e87. PMID 17542648 DOI: 10.1371/Journal.Pgen.0030087  0.481
2007 Gowri PM, Sengupta S, Bertera S, Katzenellenbogen BS. Lipin1 regulation by estrogen in uterus and liver: implications for diabetes and fertility. Endocrinology. 148: 3685-93. PMID 17463059 DOI: 10.1210/En.2006-1728  0.412
2007 Zhou HB, Sheng S, Compton DR, Kim Y, Joachimiak A, Sharma S, Carlson KE, Katzenellenbogen BS, Nettles KW, Greene GL, Katzenellenbogen JA. Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains. Journal of Medicinal Chemistry. 50: 399-403. PMID 17228884 DOI: 10.1021/Jm061035Y  0.662
2006 Mussi P, Liao L, Park SE, Ciana P, Maggi A, Katzenellenbogen BS, Xu J, O'Malley BW. Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland. Proceedings of the National Academy of Sciences of the United States of America. 103: 16716-21. PMID 17065319 DOI: 10.1073/Pnas.0607768103  0.738
2006 Likhite VS, Stossi F, Kim K, Katzenellenbogen BS, Katzenellenbogen JA. Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity. Molecular Endocrinology (Baltimore, Md.). 20: 3120-32. PMID 16945990 DOI: 10.1210/Me.2006-0068  0.696
2006 Frasor J, Chang EC, Komm B, Lin CY, Vega VB, Liu ET, Miller LD, Smeds J, Bergh J, Katzenellenbogen BS. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Research. 66: 7334-40. PMID 16849584 DOI: 10.1158/0008-5472.Can-05-4269  0.799
2006 Chang EC, Frasor J, Komm B, Katzenellenbogen BS. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology. 147: 4831-42. PMID 16809442 DOI: 10.1210/En.2006-0563  0.821
2006 Harrington WR, Sengupta S, Katzenellenbogen BS. Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells. Endocrinology. 147: 3843-50. PMID 16690804 DOI: 10.1210/En.2006-0358  0.568
2006 Stossi F, Likhite VS, Katzenellenbogen JA, Katzenellenbogen BS. Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter. The Journal of Biological Chemistry. 281: 16272-8. PMID 16608856 DOI: 10.1074/Jbc.M513405200  0.564
2006 Harrington WR, Kim SH, Funk CC, Madak-Erdogan Z, Schiff R, Katzenellenbogen JA, Katzenellenbogen BS. Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Molecular Endocrinology (Baltimore, Md.). 20: 491-502. PMID 16306086 DOI: 10.1210/Me.2005-0186  0.566
2006 Mishra RG, Stanczyk FZ, Burry KA, Oparil S, Katzenellenbogen BS, Nealen ML, Katzenellenbogen JA, Hermsmeyer RK. Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity. American Journal of Physiology. Heart and Circulatory Physiology. 290: H295-303. PMID 16199482 DOI: 10.1152/Ajpheart.00468.2005  0.369
2006 Duong V, Licznar A, Margueron R, Boulle N, Busson M, Lacroix M, Katzenellenbogen BS, Cavaillès V, Lazennec G. ERalpha and ERbeta expression and transcriptional activity are differentially regulated by HDAC inhibitors. Oncogene. 25: 1799-806. PMID 16158045 DOI: 10.1038/Sj.Onc.1209102  0.503
2006 Minutolo F, Bertini S, Martinelli A, Ortore G, Placanica G, Prota G, Rapposelli S, Tuccinardi T, Sheng S, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Macchia M. Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands Arkivoc. 2006: 83-94. DOI: 10.3998/Ark.5550190.0007.809  0.661
2005 Zhou HB, Comninos JS, Stossi F, Katzenellenbogen BS, Katzenellenbogen JA. Synthesis and evaluation of estrogen receptor ligands with bridged oxabicyclic cores containing a diarylethylene motif: estrogen antagonists of unusual structure. Journal of Medicinal Chemistry. 48: 7261-74. PMID 16279785 DOI: 10.1021/Jm0506773  0.528
2005 Frasor J, Danes JM, Funk CC, Katzenellenbogen BS. Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes. Proceedings of the National Academy of Sciences of the United States of America. 102: 13153-7. PMID 16141343 DOI: 10.1073/Pnas.0502782102  0.724
2005 De Angelis M, Stossi F, Waibel M, Katzenellenbogen BS, Katzenellenbogen JA. Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites. Bioorganic & Medicinal Chemistry. 13: 6529-42. PMID 16099659 DOI: 10.1016/J.Bmc.2005.07.014  0.443
2005 Wang C, Fan S, Li Z, Fu M, Rao M, Ma Y, Lisanti MP, Albanese C, Katzenellenbogen BS, Kushner PJ, Weber B, Rosen EM, Pestell RG. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Research. 65: 6557-67. PMID 16061635 DOI: 10.1158/0008-5472.Can-05-0486  0.48
2005 Guerini V, Sau D, Scaccianoce E, Rusmini P, Ciana P, Maggi A, Martini PG, Katzenellenbogen BS, Martini L, Motta M, Poletti A. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. Cancer Research. 65: 5445-53. PMID 15958594 DOI: 10.1158/0008-5472.Can-04-1941  0.383
2005 Rai D, Frolova A, Frasor J, Carpenter AE, Katzenellenbogen BS. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 19: 1606-17. PMID 15831524 DOI: 10.1210/Me.2004-0468  0.765
2005 Aghmesheh M, Edwards L, Clarke CL, Byth K, Katzenellenbogen BS, Russell PJ, Friedlander M, Tucker KM, de Fazio A. Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas. Gynecologic Oncology. 97: 16-25. PMID 15790432 DOI: 10.1016/J.Ygyno.2004.12.030  0.49
2005 Zhao X, Lorenc H, Stephenson H, Wang YJ, Witherspoon D, Katzenellenbogen B, Pfaff D, Vasudevan N. Thyroid hormone can increase estrogen-mediated transcription from a consensus estrogen response element in neuroblastoma cells. Proceedings of the National Academy of Sciences of the United States of America. 102: 4890-5. PMID 15778291 DOI: 10.1073/Pnas.0501042102  0.484
2005 Montano MM, Bianco NR, Deng H, Wittmann BM, Chaplin LC, Katzenellenbogen BS. Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen. Frontiers in Bioscience : a Journal and Virtual Library. 10: 1440-61. PMID 15769636 DOI: 10.2741/1630  0.536
2005 De Angelis M, Stossi F, Carlson KA, Katzenellenbogen BS, Katzenellenbogen JA. Indazole estrogens: highly selective ligands for the estrogen receptor beta. Journal of Medicinal Chemistry. 48: 1132-44. PMID 15715479 DOI: 10.1021/Jm049223G  0.458
2005 Park SE, Xu J, Frolova A, Liao L, O'Malley BW, Katzenellenbogen BS. Genetic deletion of the repressor of estrogen receptor activity (REA) enhances the response to estrogen in target tissues in vivo. Molecular and Cellular Biology. 25: 1989-99. PMID 15713652 DOI: 10.1128/Mcb.25.5.1989-1999.2005  0.699
2004 Compton DR, Sheng S, Carlson KE, Rebacz NA, Lee IY, Katzenellenbogen BS, Katzenellenbogen JA. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity. Journal of Medicinal Chemistry. 47: 5872-93. PMID 15537344 DOI: 10.1021/Jm049631K  0.688
2004 Chen Z, Katzenellenbogen BS, Katzenellenbogen JA, Zhao H. Directed evolution of human estrogen receptor variants with significantly enhanced androgen specificity and affinity. The Journal of Biological Chemistry. 279: 33855-64. PMID 15159406 DOI: 10.1074/Jbc.M402118200  0.512
2004 Katzenellenbogen BS, Frasor J. Therapeutic targeting in the estrogen receptor hormonal pathway. Seminars in Oncology. 31: 28-38. PMID 15052541 DOI: 10.1053/J.Seminoncol.2004.01.004  0.758
2004 Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology. 145: 3473-86. PMID 15033914 DOI: 10.1210/En.2003-1682  0.732
2004 Tsai HW, Katzenellenbogen JA, Katzenellenbogen BS, Shupnik MA. Protein kinase A activation of estrogen receptor α transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation Endocrinology. 145: 2730-2738. PMID 15033909 DOI: 10.1210/En.2003-1470  0.473
2004 Acevedo ML, Lee KC, Stender JD, Katzenellenbogen BS, Kraus WL. Selective recognition of distinct classes of coactivators by a ligand-inducible activation domain. Molecular Cell. 13: 725-38. PMID 15023342 DOI: 10.1016/S1097-2765(04)00121-2  0.802
2004 Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorganic & Medicinal Chemistry. 12: 1559-67. PMID 15018930 DOI: 10.1016/J.Bmc.2003.11.035  0.619
2004 Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellenbogen BS. Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Research. 64: 1522-33. PMID 14973112 DOI: 10.1158/0008-5472.Can-03-3326  0.755
2004 Nettles KW, Sun J, Radek JT, Sheng S, Rodriguez AL, Katzenellenbogen JA, Katzenellenbogen BS, Greene GL. Allosteric Control of Ligand Selectivity between Estrogen Receptors α and β: Implications for Other Nuclear Receptors Molecular Cell. 13: 317-327. PMID 14967140 DOI: 10.1016/S1097-2765(04)00054-1  0.644
2004 Barletta F, Wong CW, McNally C, Komm BS, Katzenellenbogen B, Cheskis BJ. Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc. Molecular Endocrinology (Baltimore, Md.). 18: 1096-108. PMID 14963108 DOI: 10.1210/Me.2003-0335  0.44
2003 Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology. 144: 4562-74. PMID 12959972 DOI: 10.1210/En.2003-0567  0.745
2003 Minutolo F, Antonello M, Bertini S, Ortore G, Placanica G, Rapposelli S, Sheng S, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Macchia M. Novel estrogen receptor ligands based on an anthranylaldoxime structure: Role of the phenol-type pseudocycle in the binding process Journal of Medicinal Chemistry. 46: 4032-4042. PMID 12954056 DOI: 10.1021/Jm0308390  0.583
2003 Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Molecular and Cellular Endocrinology. 206: 13-22. PMID 12943986 DOI: 10.1016/S0303-7207(03)00255-7  0.696
2003 Martini PG, Katzenellenbogen BS. Modulation of estrogen receptor activity by selective coregulators. The Journal of Steroid Biochemistry and Molecular Biology. 85: 117-22. PMID 12943695 DOI: 10.1016/S0960-0760(03)00207-3  0.618
2003 Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF, Katzenellenbogen BS. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology. 144: 3159-66. PMID 12810572 DOI: 10.1210/En.2002-0143  0.766
2003 Muthyala RS, Sheng S, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA. Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor Journal of Medicinal Chemistry. 46: 1589-1602. PMID 12699377 DOI: 10.1021/Jm0204800  0.696
2003 Sun J, Katzenellenbogen JA, Zhao H, Katzenellenbogen BS. DNA shuffling method for generating estrogen receptor α and β chimeras in yeast Biotechniques. 34: 278-288. PMID 12613251 DOI: 10.2144/03342St02  0.428
2003 Sun J, Baudry J, Katzenellenbogen JA, Katzenellenbogen BS. Molecular basis for the subtype discrimination of the estrogen receptor-β-selective ligand, diarylpropionitrile Molecular Endocrinology. 17: 247-258. PMID 12554752 DOI: 10.1210/Me.2002-0341  0.496
2003 Ghosh U, Ganessunker D, Sattigeri VJ, Carlson KE, Mortensen DJ, Katzenellenbogen BS, Katzenellenbogen JA. Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes. Bioorganic & Medicinal Chemistry. 11: 629-57. PMID 12538029 DOI: 10.1016/S0968-0896(02)00309-7  0.565
2003 Bowe J, Li XF, Sugden D, Katzenellenbogen JA, Katzenellenbogen BS, O'Byrne KT. The effects of the phytoestrogen, coumestrol, on gonadotropin-releasing hormone (GnRH) mRNA expression in GT1-7 GnRH neurones Journal of Neuroendocrinology. 15: 105-108. PMID 12535152 DOI: 10.1046/J.1365-2826.2003.00991.X  0.322
2003 Rajendran RR, Nye AC, Frasor J, Balsara RD, Martini PG, Katzenellenbogen BS. Regulation of nuclear receptor transcriptional activity by a novel DEAD box RNA helicase (DP97). The Journal of Biological Chemistry. 278: 4628-38. PMID 12466272 DOI: 10.1074/Jbc.M210066200  0.826
2003 Katzenellenbogen JA, Muthyala R, Katzenellenbogen BS. The nature of the ligand-binding pocket of estrogen receptor alpha and beta: The search for subtype-selective ligands and implications for the prediction of estrogenic activity Pure and Applied Chemistry. 75: 2397-2403. DOI: 10.1351/Pac200375112397  0.51
2003 Katzenellenbogen JA, Muthyala R, Katzenellenbogen BS. Nature of the ligand-binding pocket of estrogen receptor α and β: The search for subtype-selective ligands and implications for the prediction of estrogenic activity Pure and Applied Chemistry. 75: 2397-2403.  0.35
2002 Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS. Antagonists Selective for Estrogen Receptor α. Endocrinology. 143: 941-947. PMID 28201446 DOI: 10.1210/endo.143.3.8704  0.59
2002 Zhou Q, Nie R, Prins GS, Saunders PT, Katzenellenbogen BS, Hess RA. Localization of androgen and estrogen receptors in adult male mouse reproductive tract. Journal of Andrology. 23: 870-81. PMID 12399534 DOI: 10.1002/J.1939-4640.2002.Tb02345.X  0.383
2002 Harris HA, Katzenellenbogen JA, Katzenellenbogen BS. Characterization of the biological roles of the estrogen receptors, ERα and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligand Endocrinology. 143: 4172-4177. PMID 12399409 DOI: 10.1210/En.2002-220403  0.538
2002 Ediger TR, Park SE, Katzenellenbogen BS. Estrogen receptor inducibility of the human Na+/H+ exchanger regulatory factor/ezrin-radixin-moesin binding protein 50 (NHE-RF/EBP50) gene involving multiple half-estrogen response elements. Molecular Endocrinology (Baltimore, Md.). 16: 1828-39. PMID 12145337 DOI: 10.1210/Me.2001-0290  0.722
2002 Nye AC, Rajendran RR, Stenoien DL, Mancini MA, Katzenellenbogen BS, Belmont AS. Alteration of large-scale chromatin structure by estrogen receptor. Molecular and Cellular Biology. 22: 3437-49. PMID 11971975 DOI: 10.1128/Mcb.22.10.3437-3449.2002  0.838
2002 Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nature Structural Biology. 9: 359-64. PMID 11953755 DOI: 10.1038/Nsb787  0.489
2002 Rickard DJ, Waters KM, Ruesink TJ, Khosla S, Katzenellenbogen JA, Katzenellenbogen BS, Riggs BL, Spelsberg TC. Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts Journal of Bone and Mineral Research. 17: 580-592. PMID 11918216 DOI: 10.1359/Jbmr.2002.17.4.580  0.537
2002 Kowalski AA, Graddy LG, Vale-Cruz DS, Choi I, Katzenellenbogen BS, Simmen FA, Simmen RC. Molecular cloning of porcine estrogen receptor-beta complementary DNAs and developmental expression in periimplantation embryos. Biology of Reproduction. 66: 760-9. PMID 11870084 DOI: 10.1095/Biolreprod66.3.760  0.436
2002 Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS. Antagonists selective for estrogen receptor alpha. Endocrinology. 143: 941-7. PMID 11861516 DOI: 10.1210/Endo.143.3.8704  0.642
2002 Katzenellenbogen BS, Sun J, Harrington WR, Kraichely DM, Ganessunker D, Katzenellenbogen JA. Structure-function relationships in estrogen receptors and the characterization of novel selective estrogen receptor modulators with unique pharmacological profiles. Annals of the New York Academy of Sciences. 949: 6-15. PMID 11795381 DOI: 10.1111/J.1749-6632.2001.Tb03998.X  0.562
2001 Martini PG, Katzenellenbogen BS. Regulation of Prothymosin α Gene Expression by Estrogen in Estrogen Receptor-Containing Breast Cancer Cells via Upstream Half-Palindromic Estrogen Response Element Motifs. Endocrinology. 142: 3493-3501. PMID 28201575 DOI: 10.1210/endo.142.8.8314  0.483
2001 Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. Journal of Medicinal Chemistry. 44: 4230-51. PMID 11708925 DOI: 10.1021/Jm010254A  0.429
2001 Zhou Q, Clarke L, Nie R, Carnes K, Lai LW, Lien YHH, Verkman A, Lubahn D, Fisher JS, Katzenellenbogen BS, Hess RA. Estrogen action and male fertility: Roles of the sodium/hydrogen exchanger-3 and fluid reabsorption in reproductive tract function Proceedings of the National Academy of Sciences of the United States of America. 98: 14132-14137. PMID 11698654 DOI: 10.1073/Pnas.241245898  0.367
2001 Mortensen DS, Rodriguez AL, Carlson KE, Sun J, Katzenellenbogen BS, Katzenellenbogen JA. Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor alpha. Journal of Medicinal Chemistry. 44: 3838-48. PMID 11689070 DOI: 10.1021/Jm010211U  0.504
2001 Waters KM, Rickard DJ, Lawrence Riggs B, Khosla S, Katzenellenbogen JA, Katzenellenbogen BS, Moore J, Spelsberg TC. Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform Journal of Cellular Biochemistry. 83: 448-462. PMID 11596113 DOI: 10.1002/Jcb.1242  0.376
2001 Nuedling S, Karas RH, Mendelsohn ME, Katzenellenbogen JA, Katzenellenbogen BS, Meyer R, Vetter H, Grohé C. Activation of estrogen receptor β is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes Febs Letters. 502: 103-108. PMID 11583108 DOI: 10.1016/S0014-5793(01)02675-8  0.377
2001 Mortensen DS, Rodriguez AL, Sun J, Katzenellenbogen BS, Katzenellenbogen JA. Furans with basic side chains: synthesis and biological evaluation of a novel series of antagonists with selectivity for the estrogen receptor alpha. Bioorganic & Medicinal Chemistry Letters. 11: 2521-4. PMID 11549460 DOI: 10.1016/S0960-894X(01)00488-7  0.455
2001 Choi I, Ko C, Park-Sarge OK, Nie R, Hess RA, Graves C, Katzenellenbogen BS. Human estrogen receptor beta-specific monoclonal antibodies: characterization and use in studies of estrogen receptor beta protein expression in reproductive tissues. Molecular and Cellular Endocrinology. 181: 139-50. PMID 11476948 DOI: 10.1016/S0303-7207(01)00492-0  0.388
2001 Martini PG, Katzenellenbogen BS. Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs. Endocrinology. 142: 3493-501. PMID 11459795 DOI: 10.1210/Endo.142.8.8314  0.537
2001 Lazennec G, Thomas JA, Katzenellenbogen BS. Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators Journal of Steroid Biochemistry and Molecular Biology. 77: 193-203. PMID 11457657 DOI: 10.1016/S0960-0760(01)00060-7  0.511
2001 Tedesco R, Thomas JA, Katzenellenbogen BS, Katzenellenbogen JA. The estrogen receptor: a structure-based approach to the design of new specific hormone-receptor combinations. Chemistry & Biology. 8: 277-87. PMID 11306352 DOI: 10.1016/S1074-5521(01)00006-0  0.539
2001 Wang C, Fu M, Angeletti RH, Siconolfi-Baez L, Reutens AT, Albanese C, Lisanti MP, Katzenellenbogen BS, Kato S, Hopp T, Fuqua SA, Lopez GN, Kushner PJ, Pestell RG. Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. The Journal of Biological Chemistry. 276: 18375-83. PMID 11279135 DOI: 10.1074/Jbc.M100800200  0.484
2001 Wissink S, van der Burg B, Katzenellenbogen BS, van der Saag PT. Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogen. Molecular Endocrinology (Baltimore, Md.). 15: 543-52. PMID 11266506 DOI: 10.1210/Mend.15.4.0629  0.534
2001 Stauffer SR, Huang YR, Aron ZD, Coletta CJ, Sun J, Katzenellenbogen BS, Katzenellenbogen JA. Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists. Bioorganic & Medicinal Chemistry. 9: 151-61. PMID 11197335 DOI: 10.1016/S0968-0896(00)00226-1  0.488
2001 Kousteni S, Bellido T, Plotkin L, O'Brien C, Bodenner D, Han L, Han K, DiGregorio G, Katzenellenbogen J, Katzenellenbogen B, Roberson P, Weinstein R, Jilka R, Manolagas S. Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Cell. 104: 719-730. DOI: 10.1016/S0092-8674(01)00268-9  0.543
2000 Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS. Conformational Changes and Coactivator Recruitment by Novel Ligands for Estrogen Receptor-α and Estrogen Receptor-β: Correlations with Biological Character and Distinct Differences among SRC Coactivator Family Members. Endocrinology. 141: 3534-3545. PMID 28200959 DOI: 10.1210/endo.141.10.7698  0.339
2000 Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor alpha and estrogen receptor beta: Regulation by selective estrogen receptor modulators and importance in breast cancer Breast Cancer Research. 2: 335-344. PMID 11250726 DOI: 10.1186/Bcr78  0.577
2000 Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. The Journal of Steroid Biochemistry and Molecular Biology. 74: 279-85. PMID 11162936 DOI: 10.1016/S0960-0760(00)00104-7  0.63
2000 Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, Katzenellenbogen JA. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. Journal of Medicinal Chemistry. 43: 4934-47. PMID 11150164 DOI: 10.1021/Jm000170M  0.483
2000 Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE, Stoica A. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I Endocrinology. 141: 4503-4511. PMID 11108261 DOI: 10.1210/Endo.141.12.7836  0.439
2000 Ju YH, Carlson KE, Sun J, Pathak D, Katzenellenbogen BS, Katzenellenbogen JA, Helferich WG. Estrogenic effects of extracts from cabbage, fermented cabbage, and acidified brussels sprouts on growth and gene expression of estrogen-dependent human breast cancer (MCF-7) cells. Journal of Agricultural and Food Chemistry. 48: 4628-34. PMID 11052710 DOI: 10.1021/Jf000164Z  0.484
2000 Choi I, Gudas LJ, Katzenellenbogen BS. Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region Molecular and Cellular Endocrinology. 164: 225-237. PMID 11026574 DOI: 10.1016/S0303-7207(00)00197-0  0.513
2000 Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-α and estrogen receptor-β: Correlations with biological character and distinct differences among SRC coactivator family members Endocrinology. 141: 3534-3545. PMID 11014206 DOI: 10.1210/Endo.141.10.7698  0.529
2000 Delage-Mourroux R, Martini PG, Choi I, Kraichely DM, Hoeksema J, Katzenellenbogen BS. Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA. The Journal of Biological Chemistry. 275: 35848-56. PMID 10960470 DOI: 10.1074/Jbc.M001327200  0.582
2000 Martini PG, Delage-Mourroux R, Kraichely DM, Katzenellenbogen BS. Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Molecular and Cellular Biology. 20: 6224-32. PMID 10938099 DOI: 10.1128/Mcb.20.17.6224-6232.2000  0.611
2000 Stauffer SR, Sun J, Katzenellenbogen BS, Katzenellenbogen JA. Acyclic amides as estrogen receptor ligands: Synthesis, binding, activity and receptor interaction Bioorganic and Medicinal Chemistry. 8: 1293-1316. PMID 10896109 DOI: 10.1016/S0968-0896(00)00075-4  0.454
2000 De Haan G, Chusacultanachai S, Mao C, Katzenellenbogen BS, Shapiro DJ. Estrogen receptor-KRAB chimeras are potent ligand-dependent repressors of estrogen-regulated gene expression Journal of Biological Chemistry. 275: 13493-13501. PMID 10788463 DOI: 10.1074/Jbc.275.18.13493  0.578
2000 Stoica A, Katzenellenbogen BS, Martin MB. Activation of estrogen receptor-alpha by the heavy metal cadmium. Molecular Endocrinology (Baltimore, Md.). 14: 545-53. PMID 10770491 DOI: 10.1210/Mend.14.4.0441  0.505
2000 Katzenellenbogen BS. Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways Journal of the Society For Gynecologic Investigation. 7. PMID 10732327 DOI: 10.1016/S1071-5576(99)00058-1  0.618
2000 d'Oliveira C, van der Zee A, Frants R, Havekes L, Katzenellenbogen B, van Dijk K. Liver-specific overexpression of a constitutive active estrogen receptor alpha (ERα)-variant induces hypo lipidemia in male APOE3-leiden mice Atherosclerosis. 151: 173. DOI: 10.1016/S0021-9150(00)80784-4  0.302
1999 Sun J, Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA, Katzenellenbogen BS. Novel Ligands that Function as Selective Estrogens or Antiestrogens for Estrogen Receptor-α or Estrogen Receptor-β. Endocrinology. 140: 800-804. PMID 28204395 DOI: 10.1210/endo.140.2.6480  0.4
1999 Ediger TR, Kraus WL, Weinman EJ, Katzenellenbogen BS. Estrogen Receptor Regulation of the Na+/H+ Exchanger Regulatory Factor. Endocrinology. 140: 2976-2982. PMID 28200751 DOI: 10.1210/Endo.140.7.6885  0.591
1999 Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, Lisanti MP. Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha. The Journal of Biological Chemistry. 274: 33551-6. PMID 10559241 DOI: 10.1074/Jbc.274.47.33551  0.56
1999 Gee AC, Carlson KE, Martini PG, Katzenellenbogen BS, Katzenellenbogen JA. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Molecular Endocrinology (Baltimore, Md.). 13: 1912-23. PMID 10551784 DOI: 10.1210/Mend.13.11.0373  0.533
1999 Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S, Kushner PJ. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions Molecular Endocrinology. 13: 1672-1685. PMID 10517669 DOI: 10.1210/Mend.13.10.0357  0.519
1999 Chusacultanachai S, Glenn KA, Rodriguez AO, Read EK, Gardner JF, Katzenellenbogen BS, Shapiro DJ. Analysis of estrogen response element binding by genetically selected steroid receptor DNA binding domain mutants exhibiting altered specificity and enhanced affinity. The Journal of Biological Chemistry. 274: 23591-8. PMID 10438541 DOI: 10.1074/Jbc.274.33.23591  0.482
1999 Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes. Journal of Medicinal Chemistry. 42: 2456-68. PMID 10395487 DOI: 10.1021/Jm990101B  0.435
1999 Lazennec G, Alcorn JL, Katzenellenbogen BS. Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation Molecular Endocrinology. 13: 969-980. PMID 10379895 DOI: 10.1210/Mend.13.6.0318  0.574
1999 Lazennec G, Katzenellenbogen BS. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells Molecular and Cellular Endocrinology. 149: 93-105. PMID 10375022 DOI: 10.1016/S0303-7207(98)00254-8  0.577
1999 Montano MM, Ekena K, Delage-Mourroux R, Chang W, Martini P, Katzenellenbogen BS. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proceedings of the National Academy of Sciences of the United States of America. 96: 6947-52. PMID 10359819 DOI: 10.1073/Pnas.96.12.6947  0.629
1999 Sun J, Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA, Katzenellenbogen BS. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Endocrinology. 140: 800-4. PMID 9927308 DOI: 10.1210/Endo.140.2.6480  0.82
1998 McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS. Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimeras. Endocrinology. 139: 4513-22. PMID 9794460 DOI: 10.1210/Endo.139.11.6298  0.48
1998 Webb P, Nguyen P, Shinsako J, Anderson C, Feng W, Nguyen MP, Chen D, Huang SM, Subramanian S, McKinerney E, Katzenellenbogen BS, Stallcup MR, Kushner PJ. Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Molecular Endocrinology (Baltimore, Md.). 12: 1605-18. PMID 9773983 DOI: 10.1210/Mend.12.10.0185  0.334
1998 Montano MM, Jaiswal AK, Katzenellenbogen BS. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-α and estrogen receptor-β Journal of Biological Chemistry. 273: 25443-25449. PMID 9738013 DOI: 10.1074/Jbc.273.39.25443  0.524
1998 Clemens JW, Robker RL, Kraus WL, Katzenellenbogen BS, Richards JS. Hormone induction of progesterone receptor (PR) messenger ribonucleic acid and activation of PR promoter regions in ovarian granulosa cells: evidence for a role of cyclic adenosine 3',5'-monophosphate but not estradiol. Molecular Endocrinology (Baltimore, Md.). 12: 1201-14. PMID 9717846 DOI: 10.1210/Mend.12.8.0157  0.541
1998 Ekena K, Katzenellenbogen JA, Katzenellenbogen BS. Determinants of ligand specificity of estrogen receptor-α: Estrogen versus androgen discrimination Journal of Biological Chemistry. 273: 693-699. PMID 9422719 DOI: 10.1074/Jbc.273.2.693  0.55
1997 Katzenellenbogen BS, Korach KS. Editorial: A New Actor in the Estrogen Receptor Drama-Enter ER-β. Endocrinology. 138: 861-862. PMID 28199545 DOI: 10.1210/endo.138.3.5080  0.37
1997 Kraus WL, Weis KE, Katzenellenbogen BS. Determinants for the repression of estrogen receptor transcriptional activity by ligand-occupied progestin receptors. The Journal of Steroid Biochemistry and Molecular Biology. 63: 175-88. PMID 9459183 DOI: 10.1016/S0960-0760(97)00089-7  0.584
1997 Carlson KE, Choi I, Gee A, Katzenellenbogen BS, Katzenellenbogen JA. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: Evidence that an open pocket conformation is required for ligand interaction Biochemistry. 36: 14897-14905. PMID 9398213 DOI: 10.1021/Bi971746L  0.494
1997 Lazennec G, Ediger TR, Petz LN, Nardulli AM, Katzenellenbogen BS. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: Correlations with DNA and coregulator interactions and receptor conformational changes Molecular Endocrinology. 11: 1375-1386. PMID 9259327 DOI: 10.1210/Mend.11.9.9983  0.54
1997 Katzenellenbogen BS, Montano MM, Ekena K, Herman ME, McInerney EM. Antiestrogens: Mechanisms of action and resistance in breast cancer Breast Cancer Research and Treatment. 44: 23-38. PMID 9164675 DOI: 10.1023/A:1005835428423  0.583
1997 Aliau S, El Garrouj D, Yasri A, Katzenellenbogen BS, Borgna JL. 17 alpha (haloacetamidoalkyl) estradiols alkylate the human estrogen receptor at cysteine residues 417 and 530. Biochemistry. 36: 5861-7. PMID 9153427 DOI: 10.1021/Bi963111C  0.41
1997 Montano MM, Katzenellenbogen BS. The quinone reductase gene: A unique estrogen receptor-regulated gene that is activated by antiestrogens Proceedings of the National Academy of Sciences of the United States of America. 94: 2581-2586. PMID 9122238 DOI: 10.1073/Pnas.94.6.2581  0.572
1997 Montano MM, Kraus WL, Katzenellenbogen BS. Identification of a novel transferable cis element in the promoter of an estrogen-responsive gene that modulates sensitivity to hormone and antihormone Molecular Endocrinology. 11: 330-341. PMID 9058379 DOI: 10.1210/Mend.11.3.9899  0.539
1997 Katzenellenbogen BS, Korach KS. Editorial: A new actor in the estrogen receptor drama - Enter ER-β Endocrinology. 138: 861-862. PMID 9048583 DOI: 10.1210/Endo.138.3.5080  0.473
1997 Ekena K, Weis KE, Katzenellenbogen JA, Katzenellenbogen BS. Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens. The Journal of Biological Chemistry. 272: 5069-75. PMID 9030571 DOI: 10.1074/Jbc.272.8.5069  0.463
1996 Herman ME, Katzenellenbogen BS. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen Journal of Steroid Biochemistry and Molecular Biology. 59: 121-134. PMID 9010327 DOI: 10.1016/S0960-0760(96)00114-8  0.466
1996 McInerney EM, Ince BA, Shapiro DJ, Katzenellenbogen BS. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action Molecular Endocrinology. 10: 1519-1526. PMID 8961262 DOI: 10.1210/me.10.12.1519  0.539
1996 Weis KE, Ekena K, Thomas JA, Lazennec G, Katzenellenbogen BS. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Molecular Endocrinology (Baltimore, Md.). 10: 1388-98. PMID 8923465 DOI: 10.1210/Mend.10.11.8923465  0.553
1996 Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Molecular Endocrinology (Baltimore, Md.). 10: 230-42. PMID 8833652 DOI: 10.1210/Me.10.3.230  0.572
1996 Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones Molecular Endocrinology. 10: 119-131. PMID 8825552 DOI: 10.1210/Mend.10.2.8825552  0.446
1996 Mcinerney EM, Tsai MJ, O'Malley BW, Katzenellenbogen BS. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator Proceedings of the National Academy of Sciences of the United States of America. 93: 10069-10073. PMID 8816752 DOI: 10.1073/Pnas.93.19.10069  0.534
1996 Katzenellenbogen JA, Katzenellenbogen BS. Nuclear hormone receptors: Ligand-activated regulators of transcription and diverse cell responses Chemistry and Biology. 3: 529-536. PMID 8807884 DOI: 10.1016/S1074-5521(96)90143-X  0.506
1996 McInerney EM, Katzenellenbogen BS. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation Journal of Biological Chemistry. 271: 24172-24178. PMID 8798658 DOI: 10.1074/Jbc.271.39.24172  0.512
1996 Katzenellenbogen BS. Estrogen receptors: Bioactivities and interactions with cell signaling pathways Biology of Reproduction. 54: 287-293. PMID 8788178 DOI: 10.1095/Biolreprod54.2.287  0.613
1996 Ekena K, Weis KE, Katzenellenbogen JA, Katzenellenbogen BS. Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding. The Journal of Biological Chemistry. 271: 20053-9. PMID 8702724 DOI: 10.1074/Jbc.271.33.20053  0.539
1995 Kraus WL, Mcinerney EM, Katzenellenbogen BS. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor Proceedings of the National Academy of Sciences of the United States of America. 92: 12314-12318. PMID 8618892 DOI: 10.1073/Pnas.92.26.12314  0.531
1995 Schodin DJ, Zhuang Y, Shapiro DJ, Katzenellenbogen BS. Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness Journal of Biological Chemistry. 270: 31163-31171. PMID 8537380 DOI: 10.1074/Jbc.270.52.31163  0.472
1995 Kraus WL, Weis KE, Katzenellenbogen BS. Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Molecular and Cellular Biology. 15: 1847-57. PMID 7891678 DOI: 10.1128/Mcb.15.4.1847  0.599
1995 Zhuang Y, Katzenellenbogen BS, Shapiro DJ. Estrogen receptor mutants which do not bind 17β-estradiol dimerize and bind to the estrogen response element in vivo Molecular Endocrinology. 9: 457-466. PMID 7659089 DOI: 10.1210/Mend.9.4.7659089  0.524
1995 Ince BA, Schodin DJ, Shapiro DJ, Katzenellenbogen BS. Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors Endocrinology. 136: 3194-3199. PMID 7628351 DOI: 10.1210/Endo.136.8.7628351  0.576
1995 Katzenellenbogen BS, Montano MM, Le Goff P, Schodin DJ, Kraus WL, Bhardwaj B, Fujimoto N. Antiestrogens: mechanisms and actions in target cells. The Journal of Steroid Biochemistry and Molecular Biology. 53: 387-93. PMID 7626486 DOI: 10.1016/0960-0760(95)00084-D  0.588
1995 Nicholson RI, Gee JM, Manning DL, Wakeling AE, Montano MM, Katzenellenbogen BS. Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer. Annals of the New York Academy of Sciences. 761: 148-63. PMID 7625718 DOI: 10.1111/J.1749-6632.1995.Tb31376.X  0.408
1995 Montano MM, Muller V, Trobaugh A, Katzenellenbogen BS. The carboxy-terminal F domain of the human estrogen receptor: Role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists Molecular Endocrinology. 9: 814-825. PMID 7476965 DOI: 10.1210/Mend.9.7.7476965  0.582
1994 Le Goff P, Montano MM, Schodin DJ, Katzenellenbogen BS. Phosphorylation of the human estrogen receptor: Identification of hormone-regulated sites and examination of their influence on transcriptional activity Journal of Biological Chemistry. 269: 4458-4466. PMID 8308015  0.344
1994 Aronica SM, Kraus WL, Katzenellenbogen BS. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription Proceedings of the National Academy of Sciences of the United States of America. 91: 8517-8521. PMID 8078914 DOI: 10.1073/Pnas.91.18.8517  0.527
1994 Bergmann KE, Wooge CH, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA. Bivalent ligands as probes of estrogen receptor action Journal of Steroid Biochemistry and Molecular Biology. 49: 139-152. PMID 8031710 DOI: 10.1016/0960-0760(94)90004-3  0.58
1994 Kraus WL, Montano MM, Katzenellenbogen BS. Identification of multiple, widely spaced estrogen-responsive regions in the rat progesterone receptor gene Molecular Endocrinology. 8: 952-969. PMID 7997237 DOI: 10.1210/Mend.8.8.7997237  0.52
1994 Ince BA, Montano MM, Katzenellenbogen BS. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3′,5′-monophosphate and ligands including antiestrogens Molecular Endocrinology. 8: 1397-1406. PMID 7531820 DOI: 10.1210/Mend.8.10.7531820  0.579
1994 Fujimoto N, Katzenellenbogen BS. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: Antiestrogen selectivity and promoter dependence Molecular Endocrinology. 8: 296-304. PMID 7517003 DOI: 10.1210/Mend.8.3.7517003  0.545
1994 Cho H, Aronica SM, Katzenellenbogen BS. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: A comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors Endocrinology. 134: 658-664. PMID 7507831 DOI: 10.1210/Endo.134.2.7507831  0.422
1993 Kraus WL, Katzenellenbogen BS. Regulation of progesterone receptor gene expression and growth in the rat uterus: Modulation of estrogen actions by progesterone and sex steroid hormone antagonists Endocrinology. 132: 2371-2379. PMID 8504742 DOI: 10.1210/Endo.132.6.8504742  0.461
1993 Katzenellenbogen BS, Bhardwaj B, Fang H, Ince BA, Pakde F, Reese JC, Schodin D, Wrenn CK. Hormone binding and transcription activation by estrogen receptors: Analyses using mammalian and yeast systems Journal of Steroid Biochemistry and Molecular Biology. 47: 39-48. PMID 8274440 DOI: 10.1016/0960-0760(93)90055-2  0.592
1993 Pakdel F, Goff PL, Katzenellenbogen BS. An assessment of the role of domain F and pest sequences in estrogen receptor half-life and bioactivity Journal of Steroid Biochemistry and Molecular Biology. 46: 663-672. PMID 8274400 DOI: 10.1016/0960-0760(93)90307-I  0.461
1993 Katzenellenbogen BS, Fang H, Ince BA, Pakdel F, Reese JC, Wooge CH, Wrenn CK. Estrogen receptors: Ligand discrimination and antiestrogen action Breast Cancer Research and Treatment. 27: 17-26. PMID 8260727 DOI: 10.1007/Bf00683190  0.584
1993 Wrenn CK, Katzenellenbogen BS. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast Journal of Biological Chemistry. 268: 24089-24098. PMID 8226955  0.402
1993 Lee Kraus W, Montano MM, Katzenellenbogen BS. Cloning of the rat progesterone receptor gene 5′-region and identification of two functionally distinct promoters Molecular Endocrinology. 7: 1603-1616. PMID 8145766 DOI: 10.1210/Mend.7.12.8145766  0.542
1993 Pakdel F, Reese JC, Katzenellenbogen BS. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor Molecular Endocrinology. 7: 1408-1417. PMID 8114756 DOI: 10.1210/Mend.7.11.8114756  0.541
1993 Aronica SM, Katzenellenbogen BS. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I Molecular Endocrinology. 7: 743-752. PMID 7689695 DOI: 10.1210/Mend.7.6.7689695  0.527
1993 Cho H, Katzenellenbogen BS. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators Molecular Endocrinology. 7: 441-452. PMID 7683375 DOI: 10.1210/Mend.7.3.7683375  0.546
1992 Pakdel F, Katzenellenbogen BS. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination Journal of Biological Chemistry. 267: 3429-3437. PMID 1737796  0.429
1992 Reese JC, Katzenellenbogen BS. Characterization of a temperature-sensitive mutation in the hormone binding domain of the human estrogen receptor: Studies in cell extracts and intact cells and their implications for hormone-dependent transcriptional activation Journal of Biological Chemistry. 267: 9868-9873. PMID 1577818  0.4
1992 Wooge CH, Nilsson GM, Heierson A, McDonnell DP, Katzenellenbogen BS. Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis of truncated and full length estrogen receptors expressed in bacteria, yeast, and mammalian cells. Molecular Endocrinology (Baltimore, Md.). 6: 861-9. PMID 1495491 DOI: 10.1210/Mend.6.6.1495491  0.542
1992 Reese JC, Wooge CH, Katzenellenbogen BS. Identification of two cysteines closely positioned in the ligand-binding pocket of the human estrogen receptor: Roles in ligand binding and transcriptional activation Molecular Endocrinology. 6: 2160-2166. PMID 1491695 DOI: 10.1210/Mend.6.12.1491695  0.466
1992 Reese JC, Katzenellenbogen BS. Examination of the DNA-Binding Ability of Estrogen Receptor in Whole Cells: Implications for Hormone-Independent Transactivation and the Actions of Antiestrogens Molecular and Cellular Biology. 12: 4531-4538. PMID 1406642 DOI: 10.1128/mcb.12.10.4531-4538.1992  0.568
1992 Read LD, Katzenellenbogen BS. Characterization and regulation of estrogen and progesterone receptors in breast cancer Cancer Treatment and Research. 61: 277-299. PMID 1360237 DOI: 10.1007/978-1-4615-3500-3_14  0.491
1991 Reese JC, Katzenellenbogen BS. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor: Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands Journal of Biological Chemistry. 266: 10880-10888. PMID 2040605  0.439
1991 Pinney KG, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA. Efficient and selective photoaffinity labeling of the estrogen receptor using two nonsteroidal ligands that embody aryl azide or tetrafluoroaryl azide photoreactive functions. Biochemistry. 30: 2421-31. PMID 2001370 DOI: 10.1021/Bi00223A018  0.527
1991 Reese JC, Katzenellenbogen BS. Differential DNA-binding abilites of estrogen receptor occupied with two classes of antiestrogens: Studies using human estrogen receptor overexpressed in mammalian cells Nucleic Acids Research. 19: 6595-6602. PMID 1754396 DOI: 10.1093/Nar/19.23.6595  0.543
1991 Cho H, Ng PA, Katzenellenbogen BS. Differential regulation of gene expression by estrogen in estrogen growth- independent and -dependent MCF-7 human breast cancer cell sublines Molecular Endocrinology. 5: 1323-1330. PMID 1722871 DOI: 10.1210/Mend-5-9-1323  0.492
1991 Aronica SM, Katzenellenbogen BS. Progesterone receptor regulation in uterine cells: Stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors Endocrinology. 128: 2045-2052. PMID 1706263 DOI: 10.1210/Endo-128-4-2045  0.433
1990 Katzenellenbogen BS, Nardulli AM, Read LD. Estrogen regulation of proliferation and hormonal modulation of estrogen and progesterone receptor biosynthesis and degradation in target cells Progress in Clinical and Biological Research. 322: 201-211. PMID 2406733  0.44
1990 Katzenellenbogen BS. A tribute to Jack Gorski: estrogen receptor model builder and scientific friend to many Progress in Clinical and Biological Research. 322: 1-16. PMID 2406727  0.371
1990 Katzenellenbogen BS, Norman MJ. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: Interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen Endocrinology. 126: 891-898. PMID 2404751 DOI: 10.1210/Endo-126-2-891  0.424
1990 Wrenn CK, Katzenellenbogen BS. Cross-linking of estrogen receptor to chromatin in intact MCF-7 human breast cancer cells: Optimization and effect of ligand Molecular Endocrinology. 4: 1647-1654. PMID 2280770 DOI: 10.1210/Mend-4-11-1647  0.482
1990 Read LD, Keith D, Slamon DJ, Katzenellenbogen BS. Hormonal Modulation of HER-2/neu Protooncogene Messenger Ribonucleic Acid and pl85 Protein Expression in Human Breast Cancer Cell Lines Cancer Research. 50: 3947-3951. PMID 1972345  0.402
1989 Harlow KW, Smith DN, Katzenellenbogen JA, Greene GL, Katzenellenbogen BS. Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor. The Journal of Biological Chemistry. 264: 17476-85. PMID 2793867  0.301
1989 Read LD, Greene GL, Katzenellenbogen BS. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Molecular Endocrinology (Baltimore, Md.). 3: 295-304. PMID 2785242 DOI: 10.1210/Mend-3-2-295  0.505
1989 Clarke R, Brünner N, Katzenellenbogen BS, Thompson EW, Norman MJ, Koppi C, Paik S, Lippman ME, Dickson RB. Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America. 86: 3649-53. PMID 2726742 DOI: 10.1073/Pnas.86.10.3649  0.523
1988 Bindal RD, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA. Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol red Journal of Steroid Biochemistry. 31: 287-293. PMID 3419159 DOI: 10.1016/0022-4731(88)90352-4  0.519
1988 Read LD, Snider CE, Miller JS, Greene GL, Katzenellenbogen BS. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Molecular Endocrinology (Baltimore, Md.). 2: 263-71. PMID 3398853 DOI: 10.1210/Mend-2-3-263  0.467
1988 Mangel WF, Toledo DL, Nardulli AM, Reiner GCA, Norman MJ, Katzenellenbogen BS. Plasminogen activators in human breast cancer cell lines: Hormonal regulation and properties Journal of Steroid Biochemistry. 30: 79-88. PMID 3386280 DOI: 10.1016/0022-4731(88)90079-9  0.43
1988 Nardulli AM, Katzenellenbogen BS. Progesterone receptor regulation in T47D human breast cancer cells: Analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin Endocrinology. 122: 1532-1540. PMID 3345726 DOI: 10.1210/Endo-122-4-1532  0.477
1988 Nardulli AM, Greene GL, O'Malley BW, Katzenellenbogen BS. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology. 122: 935-44. PMID 3342760 DOI: 10.1210/Endo-122-3-935  0.492
1988 Elliston JF, Katzenellenbogen BS. Comparative analysis of estrogen receptors covalently labeled with an estrogen and an antiestrogen in several estrogen target cells as studied by limited proteolysis Journal of Steroid Biochemistry. 29: 559-569. PMID 3290576 DOI: 10.1016/0022-4731(88)90152-5  0.537
1988 Weaver CA, Springer PA, Katzenellenbogen BS. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells. Molecular Endocrinology (Baltimore, Md.). 2: 936-45. PMID 2460749 DOI: 10.1210/Mend-2-10-936  0.564
1987 Sheen YY, Katzenellenbogen BS. Antiestrogen stimulation of the production of a 37,000 molecular weight secreted protein and estrogen stimulation of the production of a 32,000 molecular weight secreted protein in MCF-7 human breast cancer cells Endocrinology. 120: 1140-1151. PMID 3803313 DOI: 10.1210/Endo-120-3-1140  0.372
1987 Katzenellenbogen BS, Elliston JF, Monsma FJ, Springer PA, Ziegler YS, Greene GL. Structural analysis of covalently labeled estrogen receptors by limited proteolysis and monoclonal antibody reactivity. Biochemistry. 26: 2364-73. PMID 3620450 DOI: 10.1021/Bi00382A043  0.328
1987 Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y. Proliferation, Hormonal Responsiveness, and Estrogen Receptor Content of MCF-7 Human Breast Cancer Cells Grown in the Short-Term and Long-Term Absence of Estrogens Cancer Research. 47: 4355-4360. PMID 3607768  0.379
1987 Elliston JF, Zablocki JA, Katzenellenbogen BS, Katzenellenbogen JA. Ketononestrol aziridine, an agonistic estrogen receptor affinity label: Study of its bioactivity and estrogen receptor covalent labeling Endocrinology. 121: 667-676. PMID 3595536 DOI: 10.1210/Endo-121-2-667  0.534
1987 Kendra KL, Katzenellenbogen BS. An evaluation of the involvement of polyamines in modulating MCF-7 human breast cancer cell proliferation and progesterone receptor levels by estrogen and antiestrogen Journal of Steroid Biochemistry. 28: 123-128. PMID 3114562 DOI: 10.1016/0022-4731(87)90367-0  0.533
1987 Zablocki JA, Katzenellenbogen JA, Carlson KE, Norman MJ, Katzenellenbogen BS. Estrogenic affinity labels: Synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrol derivatives Journal of Medicinal Chemistry. 30: 829-838. PMID 3033242 DOI: 10.1021/Jm00388A015  0.524
1987 Toney TW, Katzenellenbogen BS. An evaluation of the interactions of antiestrogens with pituitary and striatal dopamine receptors Journal of Receptors and Signal Transduction. 7: 695-712. PMID 2958626 DOI: 10.3109/10799898709056780  0.406
1986 Mullick A, Katzenellenbogen BS. Antiprogestin-receptor complexes: Differences in the interaction of the antiprogestin RU38,486 and the progestin R5020 with the progesterone receptor of human breast cancer cells Biochemical and Biophysical Research Communications. 135: 90-97. PMID 3954780 DOI: 10.1016/0006-291X(86)90946-0  0.434
1986 Reiner GCA, Katzenellenbogen BS. Characterization of Estrogen and Progesterone Receptors and the Dissociated Regulation of Growth and Progesterone Receptor Stimulation by Estrogen in MDA–MB–134 Human Breast Cancer Cells Cancer Research. 46: 1124-1131. PMID 3943090  0.495
1986 Toney TW, Katzenellenbogen BS. Antiestrogen action in the medial basal hypothalamus and pituitary of immature female rats: Insights concerning relationships among estrogen, dopamine, and prolactin Endocrinology. 119: 2661-2669. PMID 3780547 DOI: 10.1210/Endo-119-6-2661  0.383
1986 Mullick A, Katzenellenbogen BS. Progesterone receptor synthesis and degradation in MCF-7 human breast cancer cells as studied by dense amino acid incorporation. Evidence for a non-hormone binding receptor precursor Journal of Biological Chemistry. 261: 13236-13243. PMID 3759961  0.372
1986 Wei LL, Katzenellenbogen BS, Robertson DW, Simpson DM, Katzenellenbogen JA. Nitrosourea and nitrosocarbamate derivatives of the antiestrogen tamoxifen as potential estrogen receptor-mediated cytotoxic agents in human breast cancer cells Breast Cancer Research and Treatment. 7: 77-90. PMID 3719114 DOI: 10.1007/Bf01806792  0.549
1986 Nardulli AM, Katzenellenbogen BS. Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo Endocrinology. 119: 2038-2046. PMID 3533520 DOI: 10.1210/Endo-119-5-2038  0.528
1986 Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture Proceedings of the National Academy of Sciences of the United States of America. 83: 2496-2500. PMID 3458212 DOI: 10.1073/Pnas.83.8.2496  0.508
1986 Salituro FG, Carlson KE, Elliston JF, Katzenellenbogen BS, Katzenellenbogen JA. [125I]Iododesethyl tamoxifen aziridine: Synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity label Steroids. 48: 287-313. PMID 3445283 DOI: 10.1016/0039-128X(86)90017-6  0.528
1985 Sheen YY, Ruh TS, Mangel WF, Katzenellenbogen BS. Antiestrogenic Potency and Binding Characteristics of the Triphenylethylene H1285 in MCF-7 Human Breast Cancer Cells Cancer Research. 45: 4192-4199. PMID 4040807  0.446
1985 Katzenellenbogen BS, Miller MA, Mullick A, Sheen YY. Antiestrogen action in breast cancer cells: Modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites Breast Cancer Research and Treatment. 5: 231-243. PMID 4027393 DOI: 10.1007/Bf01806018  0.606
1985 Sheen YY, Simpson DM, Katzenellenbogen BS. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: Studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor Endocrinology. 117: 561-564. PMID 4017947 DOI: 10.1210/Endo-117-2-561  0.502
1985 Miller MA, Mullick A, Greene GL, Katzenellenbogen BS. Characterization of the subunit nature of nuclear estrogen receptors by chemical cross-linking and dense amino acid labeling Endocrinology. 117: 515-522. PMID 4017945 DOI: 10.1210/Endo-117-2-515  0.44
1985 Katzenellenbogen JA, Carlson KE, Katzenellenbogen BS. Facile geometric isomerization of phenolic non-steroidal estrogens and antiestrogens: Limitations to the interpretation of experiments characterizing the activity of individual isomers Journal of Steroid Biochemistry. 22: 589-596. PMID 4010284 DOI: 10.1016/0022-4731(85)90210-9  0.513
1985 Wei LL, Mangel WF, Katzenellenbogen BS. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro Journal of Steroid Biochemistry. 23: 875-881. PMID 3937947 DOI: 10.1016/0022-4731(85)90042-1  0.543
1985 Reiner GCA, Katzenellenbogen BS. Dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells Proceedings of the American Association For Cancer Research 0.428
1984 Monsma FJ, Katzenellenbogen BS, Miller MA, Ziegler YS, Katzenellenbogen JA. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen. Endocrinology. 115: 143-53. PMID 6734512 DOI: 10.1210/Endo-115-1-143  0.491
1984 Katzenellenbogen BS. Biology and receptor interactions of estriol and estriol derivatives in vitro and in vivo Journal of Steroid Biochemistry. 20: 1033-1037. PMID 6727348 DOI: 10.1016/0022-4731(84)90015-3  0.53
1984 Eckert RL, Mullick A, Rorke EA, Katzenellenbogen BS. Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique Endocrinology. 114: 629-637. PMID 6690295 DOI: 10.1210/Endo-114-2-629  0.472
1984 Miller MA, Greene GL, Katzenellenbogen BS. Estrogen receptor transformation in MCF-7 breast cancer cells: Characterization by immunochemical and sedimentation analyses Endocrinology. 114: 296-298. PMID 6690275 DOI: 10.1210/Endo-114-1-296  0.444
1984 Reiner GCA, Katzenellenbogen BS, Bindal RD, Katzenellenbogen JA. Biological Activity and Receptor Binding of a Strongly Interacting Estrogen in Human Breast Cancer Cells Cancer Research. 44: 2302-2308. PMID 6547074  0.505
1984 Miller MA, Lippman ME, Katzenellenbogen BS. Antiestrogen Binding in Antiestrogen Growth-resistant Estrogen-responsive Clonal Variants of MCF-7 Human Breast Cancer Cells Cancer Research. 44: 5038-5045. PMID 6488162  0.472
1984 Rorke EA, Katzenellenbogen BS. Dissociated regulation of growth and ornithine decarboxylase activity by estrogen in the rat uterus Biochemical and Biophysical Research Communications. 122: 1186-1193. PMID 6433909 DOI: 10.1016/0006-291X(84)91217-8  0.395
1984 Rorke EA, Kendra KL, Katzenellenbogen BS. Relationships among uterine growth, ornithine decarboxylase activity and polyamine levels: studies with estradiol and antiestrogens Molecular and Cellular Endocrinology. 38: 31-38. PMID 6394408 DOI: 10.1016/0303-7207(84)90142-4  0.32
1984 Katzenellenbogen JA, Katzenellenbogen BS. Affinity labeling of receptors for steroid and thyroid hormones Vitamins and Hormones. 213-274. DOI: 10.1016/S0083-6729(08)60091-6  0.398
1984 Miller M, Mullick A, Katzenellenbogen B. Characterization of salt-extracted nuclear antiestr0gen receptor complexes Journal of Steroid Biochemistry. 20: 1633. DOI: 10.1016/0022-4731(84)90950-6  0.381
1984 Katzenellenbogen B, Miller M, Mullick A, Sheen Y. Interaction of antiestrogens with estrogen receptors and antiestrogen binding sites Journal of Steroid Biochemistry. 20: 1629. DOI: 10.1016/0022-4731(84)90941-5  0.468
1983 Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K. Antiestrogen pharmacology and mechanism of action Journal of Steroid Biochemistry. 19: 59-68. PMID 6887873 DOI: 10.1016/S0022-4731(83)80007-7  0.573
1983 Miller MA, Katzenellenbogen BS. Characterization and quantitation of antiestrogen binding sites in estrogen receptor-positive and -negative human breast cancer cell lines Cancer Research. 43: 3094-3100. PMID 6850618  0.487
1983 Sudo K, Monsma FJ, Katzenellenbogen BS. Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat. Endocrinology. 112: 425-34. PMID 6848356 DOI: 10.1210/Endo-112-2-425  0.387
1983 Peltz SW, Katzenellenbogen BS, Kneifel MA, Mangel WF. Plasminogen activators in tissues of the immature and estrogen-stimulated rat uterus and in uterine luminal fluid: characterization and properties Endocrinology. 112: 890-897. PMID 6681601 DOI: 10.1210/Endo-112-3-890  0.369
1983 Eckert RL, Katzenellenbogen BS. Modulation of progestin binding activity in cultured human breast carcinoma cells: The effect of serum type and concentration Journal of Receptors and Signal Transduction. 3: 599-621. PMID 6672191 DOI: 10.3109/10799898309041950  0.462
1982 Kneifel MA, Leytus SP, Fletcher E, Weber T, Mangel WF, Katzenellenbogen BS. Uterine plasminogen activator activity: modulation by steroid hormones Endocrinology. 111: 493-499. PMID 7201382 DOI: 10.1210/Endo-111-2-493  0.434
1982 Eckert RL, Katzenellenbogen BS. Physical properties of estrogen receptor complexes in MCF-7 human breast cancer cells. Differences with anti-estrogen and estrogen Journal of Biological Chemistry. 257: 8840-8846. PMID 7096337  0.417
1982 Pavlik EJ, Katzenellenbogen BS. The intranuclear distribution of rat uterine estrogen receptors determined after nuclease treatment and chromatin fractionation Molecular and Cellular Endocrinology. 26: 201-216. PMID 7084560 DOI: 10.1016/0303-7207(82)90017-X  0.493
1982 Robertson DW, Katzenellenbogen JA, Long DJ, Rorke EA, Katzenellenbogen BS. Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen. Journal of Steroid Biochemistry. 16: 1-13. PMID 7062732 DOI: 10.1016/0022-4731(82)90137-6  0.364
1982 Robertson DW, Katzenellenbogen JA, Hayes JR, Katzenellenbogen BS. Antiestrogen basicity-activity relationships: A comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicity Journal of Medicinal Chemistry. 25: 167-171. PMID 7057423 DOI: 10.1021/Jm00344A015  0.457
1982 Eckert RL, Katzenellenbogen BS. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells Cancer Research. 42: 139-144. PMID 7053842  0.463
1982 Hersey RM, Weisz J, Katzenellenbogen BS. Estrogenic potency, receptor interactions, and metabolism of catechol estrogens in the immature rat uterus in vitro Endocrinology. 111: 896-903. PMID 6286287 DOI: 10.1210/Endo-111-3-896  0.544
1982 Katzenellenbogen JA, Katzenellenbogen BS. Considerations in the design and evaluation of cytotoxic estrogens Breast Cancer Research and Treatment. 2: 347-353. DOI: 10.1007/Bf01805876  0.549
1982 ROBERTSON DW, KATZENELLENBOGEN JA, HAYES JR, KATZENELLENBOGEN BS. ChemInform Abstract: ANTIESTROGEN BASICITY-ACTIVITY RELATIONSHIPS: A COMPARISON OF THE ESTROGEN RECEPTOR BINDING AND ANTIUTEROTROPHIC POTENCIES OF SEVERAL ANALOGS OF (Z)-1,2-DIPHENYL-1-(4-(2-(DIMETHYLAMINO)ETHOXY)PHENYL)-1-BUTENE (TAMOXIFEN, NOLVADEX) HAV Chemischer Informationsdienst. 13. DOI: 10.1002/Chin.198226152  0.519
1981 Katzenellenbogen BS, Rorke EA, Eckert RL. Mechanisms of estrogen and antiestrogen action in mammary cancer Journal of Steroid Biochemistry. 15: 219-229. PMID 7339248 DOI: 10.1016/0022-4731(81)90278-8  0.52
1981 Robertson DW, Wei LL, Hayes JR, Carlson KE, Katzenellenbogen JA, Katzenellenbogen BS. Tamoxifen aziridines: effective inactivators of the estrogen receptor. Endocrinology. 109: 1298-300. PMID 7285873 DOI: 10.1210/Endo-109-4-1298  0.587
1981 Eckert RL, Katzenellenbogen BS. Human endometrial cells in primary tissue culture: Modulation of the progesterone receptor level by natural and synthetic estrogens in vitro Journal of Clinical Endocrinology and Metabolism. 52: 699-708. PMID 7204540 DOI: 10.1210/Jcem-52-4-699  0.496
1981 Katzenellenbogen BS, Pavlik EJ, Robertson DW, Katzenellenbogen JA. Interaction of a high affinity anti-estrogen (α-[4-pyrrolidinoethoxy]phenyl-4-hydroxy-α'-nitrostilbene, CI628M) with uterine estrogen receptors Journal of Biological Chemistry. 256: 2908-2915. PMID 7204382  0.365
1981 de Boer W, Notides AC, Katzenellenbogen BS, Hayes JR, Katzenellenbogen JA. The capacity of the antiestrogen CI-628 to activate the estrogen receptor in vitro Endocrinology. 108: 206-212. PMID 7007019 DOI: 10.1210/Endo-108-1-206  0.45
1981 Hayes JR, Rorke EA, Robertson DW, Katzenellenbogen BS, Katzenellenbogen JA. Biological potency and uterine estrogen receptor interaction of the metabolites of the antiestrogens CI628 and U23,469 Endocrinology. 108: 164-172. PMID 7007017 DOI: 10.1210/Endo-108-1-164  0.462
1981 Kneifel MA, Katzenellenbogen BS. Comparative effects of estrogen and antiestrogen on plasma renin substrate levels and hepatic estrogen receptors in the rat Endocrinology. 108: 545-552. PMID 7004858 DOI: 10.1210/Endo-108-2-545  0.43
1980 Katzenellenbogen BS, Lan NC, Rutledge SK. Estrogen receptors of human endometrium: characterization of nuclear and cytoplasmic forms and comparisons with rat uterine receptors Journal of Steroid Biochemistry. 13: 113-122. PMID 7382488 DOI: 10.1016/0022-4731(80)90181-8  0.476
1980 Katzenellenbogen BS. Dynamics of steroid hormone receptor action Annual Review of Physiology. 17-35. PMID 6996577 DOI: 10.1146/Annurev.Ph.42.030180.000313  0.499
1980 Katzenellenbogen BS, Bhakoo HS, Ferguson ER, Lan NC, Tatee T, Tsai TS, Katzenellenbogen JA. Estrogen and antiestrogen action in reproductive tissues and tumors. Recent Progress in Hormone Research. 35: 259-300. PMID 229525 DOI: 10.1016/B978-0-12-571135-7.50010-2  0.517
1980 Eckert RL, Katzenellenbogen BS. The effects of estrogens and antiestrogens on estrogen receptor dynamics and induction of progesterone receptor in MCF-7 human breast cancer cells Journal of Cell Biology. 87.  0.469
1980 Eckert RL, Katzenellenbogen BS. Human endometrial cells in primary tissue culture: Modulation of progesterone receptor level by estrogens in vitro Biology of Reproduction. 22.  0.313
1979 Tatee T, Carlson KE, Katzenellenbogen JA, Robertson DW, Katzenellenbogen BS. Antiestrogens and antiestrogen metabolites: Preparation of tritium-labeled (±)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy]- 1,2-propanediol (U-23469) and characterization and synthesis of a biologically important metabolite Journal of Medicinal Chemistry. 22: 1509-1517. PMID 536996 DOI: 10.1021/Jm00198A015  0.354
1979 Schmidt WN, Katzenellenbogen BS. Androgen-uterine interactions: An assessment of androgen interaction with the testosterone- and estrogen-receptor systems and stimulation of uterine growth and progesterone-receptor synthesis Molecular and Cellular Endocrinology. 15: 91-108. PMID 499651 DOI: 10.1016/0303-7207(79)90010-8  0.443
1979 Pavlik EJ, Rutledge S, Eckert RL, Katzenellenbogen BS. Localization of estrogen receptors in uterine cells. An appraisal of translocation Experimental Cell Research. 123: 177-189. PMID 488181 DOI: 10.1016/0014-4827(79)90434-8  0.52
1979 Katzenellenbogen BS, Tsai TS, Tatee T, Katzenellenbogen JA. Estrogen and antiestrogen action: studies in reproductive target tissues and tumors Advances in Experimental Medicine and Biology. 117: 111-132. PMID 474274 DOI: 10.1007/978-1-4757-6589-2_6  0.522
1979 Katzenellenbogen BS, Katzenellenbogen JA, Mordecai D. Zearalenones: Characterization of the estrogenic potencies and receptor interactions of a series of fungal β-resorcylic acid lactones Endocrinology. 105: 33-40. PMID 446414 DOI: 10.1210/Endo-105-1-33  0.457
1979 Hammond B, Katzenellenbogen BS, Krauthammer N, McConnell J. Estrogenic activity of the insecticide chlordecone (Kepone) and interaction with uterine estrogen receptors Proceedings of the National Academy of Sciences of the United States of America. 76: 6641-6645. PMID 93289 DOI: 10.1073/Pnas.76.12.6641  0.537
1978 Katzenellenbogen BS, Iwamoto HS, Heiman DF, Lan NC, Katzenellenbogen JA. Stilbestrols and stilbestrol derivatives: Estrogenic potency and temporal relationships between estrogen receptor binding and uterine growth Molecular and Cellular Endocrinology. 10: 103-113. PMID 564791 DOI: 10.1016/0303-7207(78)90063-1  0.463
1978 Pavlik EJ, Katzenellenbogen BS. Human endometrial cells in primary tissue culture: Estrogen interactions and modulation of cell proliferation Journal of Clinical Endocrinology and Metabolism. 47: 333-344. PMID 263301 DOI: 10.1210/Jcem-47-2-333  0.377
1977 Bhakoo HS, Katzenellenbogen BS. Progesterone modulation of estrogen-stimulated uterine biosynthetic events and estrogen receptor levels Molecular and Cellular Endocrinology. 8: 121-134. PMID 924010 DOI: 10.1016/0303-7207(77)90024-7  0.475
1977 Katzenellenbogen BS, Ferguson ER, Lan NC. Fundamental differences in the action of estrogens and antiestrogens on the uterus: comparison between compounds with similar duration of action Endocrinology. 100: 1252-1259. PMID 849722 DOI: 10.1210/Endo-100-5-1252  0.496
1977 Ferguson ER, Katzenellenbogen BS. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels Endocrinology. 100: 1242-1251. PMID 849721 DOI: 10.1210/Endo-100-5-1242  0.442
1977 Bhakoo HS, Katzenellenbogen BS. Progesterone antagonism of estradiol-stimulated uterine 'induced protein' synthesis Molecular and Cellular Endocrinology. 8: 105-120. PMID 72697 DOI: 10.1016/0303-7207(77)90023-5  0.364
1976 Schmidt WN, Sadler MA, Katzenellenbogen BS. Androgen uterine interaction: nuclear translocation of the estrogen receptor and induction of the synthesis of the uterine induced protein (IP) by high concentrations of androgens in vitro but not in vivo Endocrinology. 98: 702-716. PMID 177269 DOI: 10.1210/Endo-98-3-702  0.505
1976 Lan NC, Katzenellenbogen BS. Temporal relationships between hormone receptor binding and biological responses in the uterus: studies with short and long acting derivatives of estriol Endocrinology. 98: 220-227. PMID 174891 DOI: 10.1210/Endo-98-1-220  0.432
1975 Katzenellenbogen BS, Gorski J. [38] Methods for assessing estrogen effects on new uterine protein synthesis In Vitro Methods in Enzymology. 36: 444-455. PMID 1110635 DOI: 10.1016/S0076-6879(75)36041-2  0.376
1975 Katzenellenbogen BS, Ferguson ER. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen Endocrinology. 97: 1-12. PMID 166821 DOI: 10.1210/Endo-97-1-1  0.517
1975 Katzenellenbogen JA, Hsiung HM, Carlson KE, McGuire WL, Kraay RJ, Katzenellenbogen BS. Iodohexestrols. II. Characterization of the binding and estrogenic activity of iodinated hexestrol derivatives, in vitro and in vivo. Biochemistry. 14: 1742-50. PMID 164893 DOI: 10.1021/Bi00679A029  0.404
1975 Katzenellenbogen BS. Synthesis and inducibility of the uterine estrogen induced protein, IP, during the rat estrous cycle: clues to uterine estrogen sensitivity Endocrinology. 96: 289-297. PMID 163181 DOI: 10.1210/Endo-96-2-289  0.47
1975 Katzenellenbogen BS, Gorski J. CHAPTER 7 – Estrogen Actions on Syntheses of Macromolecules in Target Cells Biochemical Actions of Hormones. 187-243. DOI: 10.1016/B978-0-12-452803-1.50014-8  0.387
1974 Katzenellenbogen BS, Greger NG. Ontogeny of uterine responsiveness to estrogen during early development in the rat Molecular and Cellular Endocrinology. 2: 31-42. PMID 4455530 DOI: 10.1016/0303-7207(74)90010-0  0.319
1974 Katzenellenbogen BS, Williams LB. Uterine estrogen induced protein: physical and immunological comparison with ovalbumin Proceedings of the National Academy of Sciences of the United States of America. 71: 1281-1285. PMID 4133849 DOI: 10.1073/Pnas.71.4.1281  0.332
1973 Ruh TS, Katzenellenbogen BS, Katzenellenbogen JA, Gorski J. Estrone interaction with the rat uterus: in vitro response and nuclear uptake Endocrinology. 92: 125-134. PMID 4681918 DOI: 10.1210/Endo-92-1-125  0.429
Show low-probability matches.